Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9080182229018164,2.0735085528104817,0.0,0.0,0.0,14/51,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,motor activity (GO:0003774),0.8939039819330575,2.0572326472531453,0.0,0.0,0.0,14/60,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,microtubule binding (GO:0008017),0.7855038608330065,1.8701055552481418,0.0,0.061642825810373725,0.169,48/222,5.67%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;KNSTRN;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;SKA2;HAUS8;TERF1;CEP57;MAST2;PSRC1;MAP4K4;CCDC61;HAUS4;HAUS6;MACF1;FAM161A;KIF27;TUBGCP5;SPEF1;CEP57L1;NUMA1;PRNP;MAPT;HAUS7
prerank,single-stranded DNA helicase activity (GO:0017116),0.9059863066988871,1.8675089251626769,0.0013003901170351106,0.04905379800402979,0.177,13/19,6.47%,POLQ;PIF1;RAD51;MCM5;DSCC1;RFC4;MCM6;MCM7;MCM2;DNA2;DHX9;RFC2;RFC3
prerank,DNA replication origin binding (GO:0003688),0.876064766472109,1.8506864688599007,0.0025412960609911056,0.060774616996143116,0.256,16/23,7.64%,MCM5;POLA1;ORC1;DDX11;MCM8;CDC45;MCM10;MCM6;MCM7;MCM2;CDC6;DHX9;MCM3;MCM4;ORC2;ORC3
prerank,single-stranded DNA binding (GO:0003697),0.7782331952766586,1.839038448963952,0.0,0.07408715214767922,0.341,34/93,7.36%,NEIL3;RAD51AP1;RAD51B;RAD51;MCM5;POLA1;DDX11;RAD51AP2;HMGB2;BRCA2;MCM8;CDC45;DMC1;SMC6;FAM111A;MCM10;MCM6;MCM7;MCM2;RBBP8;RPA1;STN1;MSH3;ERCC4;TDP2;DHX9;HNRNPA1;BLM;MAPT;MCM3;RPA2;MCM4;MLH1;NUCKS1
prerank,kinesin binding (GO:0019894),0.8323064210444452,1.816363600446353,0.002442002442002442,0.11447953364783692,0.534,3/27,0.71%,PRC1;KIF18B;FAM83D
prerank,ligand-gated anion channel activity (GO:0099095),-0.6114858302356833,-1.8114768345657086,0.0,0.8055624218711377,0.375,11/17,15.05%,GABRB1;GABRB3;GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,DNA polymerase activity (GO:0034061),0.8412768344388353,1.8017333829955222,0.006578947368421052,0.14260329773737865,0.643,8/22,5.93%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8945048316238944,1.7984197323925233,0.004261363636363636,0.13592291325010422,0.674,4/13,4.70%,EXO1;ZGRF1;GEN1;DNA2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8480665668801384,1.7906687954415625,0.005376344086021506,0.1464668269607049,0.733,8/21,5.93%,POLK;POLQ;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,3'-5' DNA helicase activity (GO:0043138),0.8686078828630396,1.7781853330625534,0.008141112618724558,0.17308926632797642,0.811,9/16,6.08%,NAV2;MCM5;MCM6;MCM7;MCM2;DHX9;BLM;RECQL;ERCC3
prerank,DNA secondary structure binding (GO:0000217),0.8226451266948926,1.7754270554845992,0.003592814371257485,0.16669609233227825,0.821,16/31,9.83%,NEIL3;RAD51AP1;CLSPN;RAD51B;GEN1;RAD18;HMGB2;XRCC2;RBBP8;LIN54;BLM;MAPT;RAD51C;HMGB3;HMGB1;KMT2A
prerank,"DNA binding, bending (GO:0008301)",0.878113107650542,1.7643842963971421,0.009655172413793104,0.1857966862453518,0.883,3/14,1.68%,TOP2A;HMGB2;TERF1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7782779804422779,1.763293314244477,0.004509582863585118,0.17661847878062817,0.885,10/42,6.37%,CCNF;CCNB1;CCNE2;CKS2;CCNB2;CDKN2D;CDKN2C;CCNA2;CCNA1;CCNE1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5204915842904148,-1.7543730603144467,0.0056179775280898875,0.7254595919289797,0.568,10/26,15.78%,SLC6A6;SLC16A12;SLC6A1;MPC1;SLC27A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11
prerank,tubulin binding (GO:0015631),0.7343533511777163,1.7460873400788293,0.0,0.2190201435365767,0.929,39/296,2.52%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;BRCA1;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;BRCA2;SKA2;HAUS8;TERF1;CEP57;STMN1;MAST2;PSRC1;MAP4K4;CCDC61;HAUS6
prerank,GABA-A receptor activity (GO:0004890),-0.5886532425125076,-1.740983180954163,0.0040650406504065045,0.5410719456470305,0.605,8/18,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,MHC class II protein complex binding (GO:0023026),-0.682329357332042,-1.7361375807556658,0.003125,0.4254518231833495,0.622,5/11,10.73%,HSP90AB1;ATP1B1;ANXA11;PKM;CD81
prerank,damaged DNA binding (GO:0003684),0.7540517031186228,1.705426626314081,0.007874015748031496,0.37322126401738603,0.994,18/44,11.89%,NEIL3;POLQ;RAD18;HMGB2;AUNIP;SMC6;RBBP8;RPA1;RAD1;ERCC4;POLD1;RPA2;ERCC3;CUL4B;HMGB1;XPA;PCNA;FANCG
prerank,glutamate receptor binding (GO:0035254),-0.5774074350402555,-1.7009497683260546,0.019455252918287938,0.4739669333936,0.738,9/17,14.03%,SHANK3;SYNDIG1;IGSF11;HOMER1;SQSTM1;SHISA6;SHANK1;DLG4;HIP1
prerank,endodeoxyribonuclease activity (GO:0004520),0.801068220714546,1.6916194010651233,0.021601016518424398,0.4189873595263514,0.999,6/20,5.31%,EXO1;ZRANB3;RBBP8;ERCC4;DNA2;MRE11
prerank,glycine binding (GO:0016594),-0.6740832013261211,-1.691377877831889,0.00949367088607595,0.4297340499412636,0.759,6/11,14.10%,GRIN3A;GLRB;GLRA1;GRIN2B;GLRA3;GRIN1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.875938835871282,1.691278368068428,0.017964071856287425,0.3976396369176221,0.999,2/11,3.96%,NEIL3;APEX2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.5176491779549118,-1.6861155597976347,0.006134969325153374,0.39144590481167857,0.782,15/27,17.83%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1
prerank,microtubule plus-end binding (GO:0051010),0.8043273329143685,1.6811042527294144,0.017082785808147174,0.42482828136326506,0.999,4/20,4.91%,KIF2C;KNSTRN;KIF18A;NUMA1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6319641585198679,-1.6766343863528272,0.010344827586206896,0.36971990140755545,0.803,8/12,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.8043566234167172,1.6674343465792827,0.04336043360433604,0.4693102745323594,1.0,1/16,0.14%,NEIL3
prerank,GABA receptor activity (GO:0016917),-0.5221949604951104,-1.666547879294606,0.008733624454148471,0.3608825608924484,0.839,9/21,15.05%,GABRB1;GABRB3;GABRA2;GABBR1;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,anion channel activity (GO:0005253),-0.4085540684351273,-1.6629150018422885,0.01694915254237288,0.3331068626273898,0.844,21/61,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GPR89B;GPR89A;GABRA5;GABRB2;ANO4;GABRG2;LRRC8B;LRRC8D;GABRG1;TTYH3
prerank,methylation-dependent protein binding (GO:0140034),0.7215511004783235,1.662348259743095,0.006535947712418301,0.47342186341689446,1.0,14/57,8.79%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,ATP hydrolysis activity (GO:0140603),0.7501406065203902,1.6570030899460324,0.012415349887133182,0.4784225206780799,1.0,6/41,4.75%,KIF20B;KIF14;ABCA4;CHD1L;DNA2;DHX9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.4733848909680912,-1.6425416498537107,0.00641025641025641,0.35531032286521613,0.885,17/33,20.05%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1;TCERG1;PARK7
prerank,amino acid binding (GO:0016597),-0.47129710870563185,-1.640942608262688,0.0064516129032258064,0.3306130952801339,0.888,8/31,7.45%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;GLRA3;AARS1
prerank,methylated histone binding (GO:0035064),0.7041277046301939,1.6346824578909203,0.008592910848549946,0.5700734570656852,1.0,14/62,8.79%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,protein kinase C binding (GO:0005080),0.7039376128386857,1.6237952854853495,0.02914798206278027,0.6048159652134028,1.0,1/43,0.01%,TOP2A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5843668816645273,-1.617844693057042,0.02527075812274368,0.36784521616398896,0.932,9/15,15.37%,HS3ST4;HS3ST1;HS6ST3;NDST3;NDST1;HS3ST3B1;HS3ST3A1;NDST2;NDST4
prerank,acylglycerol lipase activity (GO:0047372),-0.6414454870464018,-1.6137465238928144,0.02572347266881029,0.3525819981011975,0.937,4/11,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.8511205252392313,1.60500428601838,0.05206738131699847,0.6818912026967258,1.0,3/10,5.93%,EXO1;MGME1;POLD1
prerank,ligand-gated ion channel activity (GO:0015276),-0.4766461704729946,-1.5977803967034165,0.037037037037037035,0.37048818326706356,0.956,8/30,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5348758013491517,-1.5957292180662341,0.0353356890459364,0.33392478275554505,0.957,6/16,15.03%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5348758013491517,-1.5957292180662341,0.0353356890459364,0.33392478275554505,0.957,6/16,15.03%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,ligand-gated channel activity (GO:0022834),-0.4784506724978335,-1.5927844985244655,0.030120481927710843,0.3224264853017687,0.961,8/29,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,histone acetyltransferase binding (GO:0035035),0.7501439332051586,1.5910134038333803,0.06068601583113457,0.7347384053660093,1.0,2/21,1.27%,KANSL1;GLI3
prerank,ubiquitin binding (GO:0043130),0.6614525855702068,1.5740836470635398,0.02446808510638298,0.8081737825206692,1.0,14/73,11.68%,TOP2A;CKS2;RNF168;NEDD4;FAF1;CXCR4;BUB3;FBXW7;UBE2N;RNF31;USP16;IKBKG;ADRM1;ILRUN
prerank,lipoprotein particle receptor binding (GO:0070325),-0.46931837030973134,-1.5610617584160709,0.03317535545023697,0.38357085003087055,0.98,11/27,17.78%,APOE;HSP90B1;SYT1;LRP1;DNAJA1;RELN;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,glutamate receptor activity (GO:0008066),-0.5208283938794033,-1.5595065483530801,0.048,0.36832188031894236,0.981,11/19,21.39%,GRM7;GRIK1;GRM3;GRID2;GRIK4;GRIA1;GRM5;GRM1;GRIA2;GRIK2;GRID1
prerank,MHC class I protein binding (GO:0042288),-0.5945022854937418,-1.5574254421340847,0.04276315789473684,0.3557486867961256,0.984,7/13,29.48%,TAPBP;DERL1;ATP5F1A;ATP5F1B;TAP2;TUBB4B;ABCB9
prerank,phospholipase A2 activity (GO:0004623),-0.47608270991408913,-1.557281070948798,0.03535353535353535,0.3399904848917159,0.984,10/26,30.81%,PLA2G4A;PLAAT3;PNPLA8;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PNPLA3;PLA2G4E;PLA2G4C
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6969881280729107,1.5570976100813856,0.053003533568904596,0.8839606027173713,1.0,7/34,8.13%,CCNB1;INCENP;CKS2;DBF4;STK3;ETAA1;CAB39L
prerank,chloride channel activity (GO:0005254),-0.37891514663071857,-1.55221986946247,0.034482758620689655,0.337364995014799,0.987,18/59,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GABRA5;GABRB2;ANO4;GABRG2;TTYH2;GABRG1;TTYH3
prerank,four-way junction DNA binding (GO:0000400),0.7639526333851613,1.5505821665785275,0.06342780026990553,0.8923689698542059,1.0,10/17,13.91%,RAD51B;GEN1;HMGB2;XRCC2;BLM;RAD51C;HMGB3;HMGB1;MSH6;YY1
prerank,nuclear export signal receptor activity (GO:0005049),0.7753289296029301,1.5435567419670595,0.08544303797468354,0.9042394800211865,1.0,5/11,6.03%,RANBP17;XPO1;XPO4;EIF4ENIF1;CSE1L
prerank,RNA polymerase binding (GO:0070063),0.74581452575552,1.5395907862935558,0.07887700534759358,0.8982600418973724,1.0,4/18,4.75%,BRCA1;ANP32B;NEDD4;DHX9
prerank,magnesium ion binding (GO:0000287),0.6392063819386067,1.5330061100898384,0.004036326942482341,0.908254945787003,1.0,27/135,10.24%,TOP2A;PIF1;PLK1;FIGNL1;GEN1;MAST2;NLK;IDH3A;TDP2;DYRK3;GSS;HPRT1;NUDT5;STK3;PDXK;RAP2A;MAP3K20;HPGDS;CDC42BPA;LRRK2;PGM1;TPPP;PPA1;MARK2;TKT;EYA2;CDC42BPG
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6228756304651523,-1.5317935700344458,0.05397727272727273,0.37154614517196,0.994,6/10,13.64%,SHANK3;IGSF11;SQSTM1;SHISA6;SHANK1;DLG4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.6223286309693365,-1.531758488183696,0.013289036544850499,0.35680520929706977,0.994,6/11,24.04%,PRMT3;PRMT2;PRMT8;PRMT1;PRMT9;FBXO11
prerank,protein kinase regulator activity (GO:0019887),0.6466810939331342,1.5255008777082248,0.018499486125385406,0.9236689409093474,1.0,13/95,6.75%,TPX2;CCNF;CCNB1;CCNE2;CCNB2;SPDYA;PARVA;GPRC5A;CCNA2;FAF1;CCNA1;CCNE1;WNK1
prerank,transcription corepressor binding (GO:0001222),0.6867704657542425,1.5216275848971934,0.08160779537149818,0.918999029863107,1.0,8/27,7.89%,EZH2;SUZ12;HDGF;EED;WIZ;CTBP1;LCOR;PHF1
prerank,poly(U) RNA binding (GO:0008266),0.7362032937133686,1.5209075059062427,0.09271523178807947,0.8968100931679843,1.0,12/20,16.10%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.43472159868458676,-1.5130949675669887,0.03488372093023256,0.38708617168710535,0.998,11/29,11.29%,GRIK1;GABRB1;GABRB3;GABRA2;GRID2;GRIK4;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2
prerank,WW domain binding (GO:0050699),0.7026475774808089,1.5068806390836722,0.08921933085501858,0.9486628310159864,1.0,4/26,9.23%,KIF20B;NFE2;PMEPA1;CDC25C
prerank,5'-3' exonuclease activity (GO:0008409),0.7589144205087125,1.504958483586552,0.10511756569847856,0.9337233820503964,1.0,2/14,5.31%,EXO1;MRE11
prerank,single-stranded telomeric DNA binding (GO:0043047),0.773244239165874,1.5013588808044978,0.10227272727272728,0.9275897276039151,1.0,9/11,18.74%,TERF1;RPA1;STN1;HNRNPA1;RPA2;TERF2;HNRNPA2B1;TERF2IP;RAD50
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5505116849147812,-1.496893764461063,0.06060606060606061,0.41221330516705296,0.998,8/13,15.05%,GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRG2;GABRG1
prerank,telomeric DNA binding (GO:0042162),0.6677720094878344,1.496283627679889,0.09165687426556991,0.9306975870907528,1.0,16/32,19.60%,PIF1;TERF1;RPA1;HNRNPD;STN1;BLM;TERF2;SMG6;HNRNPA2B1;PURA;UPF2;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,deoxyribonuclease activity (GO:0004536),0.7456038180999028,1.493329252208482,0.11064425770308123,0.9227323277642986,1.0,4/14,10.28%,ZRANB3;ERCC4;MRE11;MBD4
prerank,poly-pyrimidine tract binding (GO:0008187),0.7060128798470202,1.4908173644659803,0.09796437659033079,0.9140968264364145,1.0,13/23,16.10%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;HNRNPU;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,nuclease activity (GO:0004518),0.6469794823225699,1.4878751650910929,0.05754614549402823,0.9084978375386034,1.0,7/52,7.56%,EXO1;ANKLE1;REXO5;RNASE6;DNA2;MRE11;RNASEH2A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5549191563745757,-1.484919635634917,0.07947019867549669,0.42761092911170956,0.999,9/13,33.02%,TRMT11;THUMPD3;TRMT10B;TRMT1;METTL1;TRMT10A;WDR4;TRMT1L;TRMT10C
prerank,DNA polymerase binding (GO:0070182),0.7241520219512018,1.4807880108674687,0.10376134889753567,0.9234309329962144,1.0,9/18,13.89%,FANCD2;RAD51;FANCI;RTEL1;SMARCA4;LONP1;HMGB1;PCNA;SMG6
prerank,nuclear localization sequence binding (GO:0008139),0.7107313729407376,1.4751401882240263,0.12021857923497267,0.9310355611513041,1.0,7/18,15.75%,KPNA2;KPNA3;BRAP;TNPO1;NUP214;KPNA4;IPO5
prerank,kinase activator activity (GO:0019209),0.6630783961346371,1.4576202094193382,0.1089588377723971,0.9965879575615163,1.0,9/30,14.76%,TPX2;SPDYA;GPRC5A;WNK1;MARK2;STRADA;CAB39;STK11;RPTOR
prerank,DNA binding (GO:0003677),0.6116129327241829,1.4546820291745681,0.0,0.990154404420703,1.0,156/694,12.80%,TOP2A;NEIL3;BRCA1;EXO1;RAD51AP1;POLQ;NR2E3;PHF19;BRIP1;POLE;CLSPN;RAD51B;E2F2;ATAD5;RAD51;PBX4;MCM5;POLA1;GLI2;ORC1;RAD18;TCFL5;WDR76;DDX11;RAD51AP2;HMGB2;E2F1;BRCA2;TIPIN;FOXE1;MCM8;TERF1;CDC45;ILF3;DMC1;MND1;AUNIP;CCDC25;SMC1A;TIMELESS;SMC6;FAM111A;MCM10;CBFB;MCM6;SETX;MCM7;MCM2;PDS5B;TEAD1;RBBP8;HDGF;CTCF;E2F3;RPA1;NFE2;STN1;MSH3;SMARCAD1;MBD1;RAD1;ERCC4;KHDRBS1;CUX1;DNA2;TDP2;DHX9;AIFM2;PRKDC;HNRNPA1;TCF7L1;BLM;MRE11;TSHZ1;NFIB;THRAP3;MAPT;MAEL;MCM3;IKZF1;POLD1;RPA2;MCM4;GZF1;ERCC3;RFC1;YAF2;TCF7L2;PSIP1;SOX6;HP1BP3;RFC3;HOXA7;GRHL2;TCF4;DNASE2;ARID1A;RFX2;MLH1;TAF12;NUCKS1;POLR2A;POU2F1;POU3F2;SIM1;RC3H2;PHF1;LIN9;FOXO3;TRIM28;KDM2B;PLAGL2;IRF1;RAD51C;HMGB3;BCLAF1;GTF3C4;SMARCA4;MSL3;TIGD2;NFYA;CUL4B;ARID4A;PLAGL1;LONP1;HMGB1;MEOX2;NR4A2;CARF;MBD4;CXXC5;SFPQ;HNRNPU;CRLF3;XPA;GTF2A1;PCNA;CHD2;QRICH1;AHR;NKX2-1;TAF4;FANCG;APLP2;SPTY2D1;FUBP1;RBPJ;NR4A1;MSH6;ZIC4;KMT2D;SMAD4;HDAC2;ATF5;ZNF496;ILF2
prerank,protein kinase activator activity (GO:0030295),0.6308354974655157,1.4516297982981698,0.06086956521739131,0.9836251689394008,1.0,17/60,15.21%,TPX2;INCENP;DBF4;SPDYA;GPRC5A;STK3;WNK1;ETAA1;CAB39L;ABI1;MARK2;CALM2;STRADA;CAB39;STK11;RPTOR;TAOK1
prerank,acetyltransferase activity (GO:0016407),0.653565367444535,1.4514391963119675,0.11652794292508918,0.9642905896721374,1.0,2/31,1.96%,ESCO2;NAT14
prerank,exonuclease activity (GO:0004527),0.6289830450342051,1.4409116846329155,0.09856035437430787,0.9947369599943062,1.0,19/46,19.04%,EXO1;REXO5;APEX2;RAD1;MRE11;EXD1;ERI1;ENPP2;ENPP3;CNOT6;ENPP1;EXOSC7;DXO;CNOT7;EXOSC10;DCLRE1C;RAD50;XRN2;ISG20L2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.6511129224464979,1.4395122528328206,0.10836277974087162,0.9815795211928497,1.0,7/34,7.48%,EZH2;KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,voltage-gated cation channel activity (GO:0022843),-0.3331488600233278,-1.4395100906010887,0.04,0.5351827980976072,1.0,30/97,20.41%,CACNA2D1;GRIN3A;GRIN2A;KCNC2;HCN1;KCNB1;GRIN2B;KCNQ3;KCNH1;CACNG7;CACNA1B;CACNG4;KCNS3;KCNH7;OPRM1;NCS1;KCNA6;KCNA2;CACNG2;CACNB2;GRIN1;KCNC1;CACNG3;CACNG8;CACNB1;CACHD1;KCNQ1;CACNA2D2;KCNK1;LRRC38
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.4984507475324598,-1.4381326888545771,0.10212765957446808,0.5224316644655221,1.0,13/18,36.43%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;WDR81;PIK3R5;SOCS6;CISH;SOCS3;CCKBR;AGAP2
prerank,ATPase binding (GO:0051117),-0.34634214435242117,-1.4363001035054013,0.0,0.5108932166548238,1.0,31/71,24.17%,ATP6V0A1;PSEN1;ATP1B1;ATXN3;CAV1;ATP6V1E1;AR;RALB;ATP6V0A4;NCSTN;ESR1;TMEM106B;DERL1;ATP1B3;SELENOS;TRPC1;NUFIP1;NKD2;METTL21A;UBXN1;SNU13;NR1H2;SYVN1;PDE4D;SVIP;GABARAPL2;PEX26;S100A1;PIH1D1;SNX10;WFS1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.41081072719752765,-1.4362009392904544,0.039735099337748346,0.4803879835696381,1.0,18/34,25.19%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.41081072719752765,-1.4362009392904544,0.039735099337748346,0.4803879835696381,1.0,18/34,25.19%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,water transmembrane transporter activity (GO:0005372),0.7526875489506708,1.4342622980893467,0.12042682926829268,0.9876641328474047,1.0,2/11,5.71%,AQP1;PDPN
prerank,BMP binding (GO:0036122),-0.568759729470601,-1.427443145859766,0.1,0.48955186800942724,1.0,3/11,14.92%,NBL1;BMPR2;ENG
prerank,amyloid-beta binding (GO:0001540),-0.34158937377527016,-1.4222214003608122,0.047619047619047616,0.48787157557223876,1.0,29/79,18.54%,ITM2B;CST3;GRIN2A;APOE;APBA1;ITM2A;INSR;GRIN2B;TGFB2;TLR4;LRP1;EPHB2;CACNA1B;TM2D1;FZD4;CHRNA7;GRIA1;ATP1A3;CRYAB;GSAP;APBB2;PFDN5;LDLRAP1;GRIN1;GRIA2;APBB1;SORL1;NLGN1;APBA2
prerank,histone deacetylase binding (GO:0042826),0.6124194364714851,1.4200409767609896,0.055842812823164424,1.0,1.0,15/88,11.37%,TOP2A;KPNA2;GLI3;MIER1;SP2;BCOR;BHLHE41;LCOR;RBBP4;NIPBL;MIER3;MTA3;SFPQ;TAL1;HDAC1
prerank,carboxylic acid binding (GO:0031406),-0.388626072492156,-1.4194862562790067,0.06428571428571428,0.48212835380280106,1.0,9/38,7.38%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;SESN3;PSAP;GLRA3
prerank,gamma-tubulin binding (GO:0043015),0.6737099232487735,1.4169027360661595,0.14052697616060225,1.0,1.0,6/22,10.88%,RACGAP1;CDK5RAP2;BRCA2;TUBGCP5;CENPJ;NDRG1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5522128364806427,-1.4133179004089482,0.08974358974358974,0.48478347055254106,1.0,7/12,14.53%,INSR;IGF1;SOCS2;PIK3R1;IGF2;IRS1;SHC1
prerank,lysine N-methyltransferase activity (GO:0016278),0.6744150042605053,1.4085468296482269,0.14285714285714285,1.0,1.0,6/20,7.48%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6365775290642983,1.4075686893484944,0.1188235294117647,1.0,1.0,4/35,2.43%,MELK;MATK;DYRK1A;STYK1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.6455853604986167,1.4068281434843157,0.13961813842482101,1.0,1.0,6/28,11.49%,EXO1;AGO2;RNASEH2A;RPP40;RPP30;POP1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.708562910228499,1.4050462918635658,0.128698224852071,1.0,1.0,4/11,6.98%,ALDH3A1;RDH11;RDH12;RDH14
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3955634015668076,-1.404574301896222,0.0738255033557047,0.4953727641159781,1.0,9/32,19.39%,KCNC2;KCNB1;KCNQ3;KCNH1;KCNS3;KCNA6;KCNA2;KCNC1;KCNQ1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6536758111982482,1.401289585980642,0.13846153846153847,1.0,1.0,3/22,9.29%,CDKN3;DUSP12;MTMR2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.43190139657270166,-1.4003217703501027,0.09278350515463918,0.49274672603509484,1.0,7/22,15.03%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4812526337416941,-1.399655002019401,0.08270676691729323,0.48212835380280106,1.0,10/17,23.69%,GRIK1;GRIN3A;GRIN2A;GRIN2B;GRIK4;GRIA1;GRIN1;GRIA2;GRIK2;PTK2B
prerank,microtubule minus-end binding (GO:0051011),0.7034472107918633,1.398153237000148,0.1502086230876217,1.0,1.0,5/13,5.67%,HAUS4;MACF1;TUBGCP5;NUMA1;HAUS7
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7057321913399398,1.3964185269164322,0.13596491228070176,0.9985993079811505,1.0,1/12,0.46%,CDK1
prerank,phospholipase inhibitor activity (GO:0004859),0.743626329828702,1.3963917631013212,0.14390602055800295,0.9822857592479664,1.0,4/10,11.46%,ANXA9;ANXA2;ANXA5;ANXA1
prerank,nuclear import signal receptor activity (GO:0061608),0.6923718826300541,1.393505018233019,0.15629322268326418,0.9791574986685059,1.0,3/15,5.14%,KPNA2;KPNA3;TNPO1
prerank,nucleotidyltransferase activity (GO:0016779),0.6524262825578365,1.3858350126855103,0.17487046632124353,0.995601231353597,1.0,9/19,16.10%,TENT2;CRPPA;NUDT5;TENT4A;PAPSS2;TUT1;TUT7;TUT4;PNPT1
prerank,retinoic acid binding (GO:0001972),0.6998957268928746,1.3823314935136881,0.1709039548022599,0.9951843533118433,1.0,1/12,3.24%,CYP26B1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.7024611229998896,1.3773039370655737,0.17982456140350878,1.0,1.0,3/10,7.48%,NSD2;SETD3;SETD2
prerank,lipase activity (GO:0016298),-0.37261794897798595,-1.3768948937718988,0.06542056074766354,0.530123698756639,1.0,9/43,9.48%,LIPA;ABHD6;ABHD12;ABHD5;ABHD16A;PLA1A;LYPLA1;PNPLA8;ABHD2
prerank,MAP-kinase scaffold activity (GO:0005078),0.6962644820290411,1.3765958417588515,0.17091454272863568,0.9894686452848253,1.0,4/11,11.79%,KSR1;SPAG9;SH3RF1;MAPK8IP3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.49871059452077926,-1.3699167657881655,0.10861423220973783,0.5350624341464284,1.0,11/15,35.27%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;PIK3R5;SOCS6;CISH;SOCS3;CCKBR
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.33377755245875274,-1.3689446287129878,0.024390243902439025,0.5247631641230458,1.0,14/60,6.42%,EPHA5;ACVR1;FLT1;TEK;NTRK2;MERTK;ACVR2A;TGFBR2;INSR;ACVRL1;PDGFRB;EPHB2;NTRK3;TIE1
prerank,kinase binding (GO:0019900),0.569282224235575,1.3652597882800612,0.002,1.0,1.0,48/435,6.98%,KIF11;PRC1;TPX2;KIF14;CCNB1;SGO1;PLK1;FAM83D;BARD1;RACGAP1;CKS2;BORA;KIF20A;AURKB;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;CDKN2C;TRIML2;RB1;AURKA;TICAM1;TRIP6;TTC28;RHOA;CEP43;CDC6;GSK3B;MAPK4;CHEK2;CCNA2;ADD2;MAPT;VRK2;FAF1;EIF4ENIF1;PTPN2;MAP3K1;TCF7L2;USP37;WNK1;CDC25B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6422962373127854,1.353837042274063,0.1641025641025641,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6422962373127854,1.353837042274063,0.1641025641025641,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5250902179002946,-1.3523669734292822,0.08904109589041095,0.558074904832866,1.0,7/12,20.56%,VEGFC;CDH5;CADM4;VEGFA;VEGFB;VEGFD;ITGB3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5451635320477317,-1.3516937769100072,0.1,0.5473861309841902,1.0,6/11,25.07%,LEF1;ZXDC;SRRM2;GATA2;HMGA2;THAP7
prerank,retinoid binding (GO:0005501),0.6437147916387489,1.350557259103074,0.183206106870229,1.0,1.0,3/22,4.11%,CYP26B1;ABCA4;ALDH1A2
prerank,SH3 domain binding (GO:0017124),-0.3293421102278983,-1.3497732174390569,0.03389830508474576,0.540184834732987,1.0,24/62,18.94%,SGIP1;ENAH;PRKN;SHANK3;RUFY2;ELMO1;WIPF1;AFAP1L1;ADAM15;PTPN22;RUFY1;ABL1;GRB2;ARHGAP27;SHANK1;SYNJ2;CASP9;CBLB;SYNJ1;CBL;GPX1;AFAP1L2;MICAL1;PTPN12
prerank,phospholipid transfer activity (GO:0120014),-0.43186216524512944,-1.348288815631903,0.11016949152542373,0.5326468386840255,1.0,12/21,25.83%,CERT1;PLTP;MTTP;GLTP;TNFAIP8L3;PRELID3B;OSBPL2;PLEKHA8;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6967500369601323,1.3459540018468519,0.18039772727272727,1.0,1.0,6/12,15.28%,PNLDC1;CNOT1;CNOT6L;CNOT6;PAN3;CNOT7
prerank,chemorepellent activity (GO:0045499),-0.4222758122382368,-1.3452447552941271,0.10227272727272728,0.5288864915638485,1.0,9/25,19.19%,NRG3;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B
prerank,protein kinase binding (GO:0019901),0.5609185008176859,1.3428379872144194,0.002,1.0,1.0,48/480,6.98%,TOP2A;KIF11;PRC1;TPX2;KIF14;CCNB1;PLK1;FAM83D;RACGAP1;CKS2;BORA;KIF20A;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;PPM1D;CDKN2C;TRIML2;AURKA;TICAM1;RHOA;CEP43;MAP4K2;GSK3B;MAPK4;CHEK2;KHDRBS1;CCNA2;SPAG9;PDE3B;ADD2;MAPT;VRK2;FAF1;PTPN2;MAP3K1;TCF7L2;CAVIN3;USP37;TPR;WNK1;CDC25B
prerank,histone methyltransferase binding (GO:1990226),0.6789618390207008,1.3339971776621422,0.19111111111111112,1.0,1.0,5/11,10.12%,LCORL;WIZ;LCOR;PHF1;CBX1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.4281648861126528,-1.328625310456253,0.11666666666666667,0.5617376738184768,1.0,9/22,17.78%,APOE;HSP90B1;SYT1;DNAJA1;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,transcription coregulator binding (GO:0001221),0.5761479882748325,1.327679446777277,0.16537180910099888,1.0,1.0,15/50,14.79%,EZH2;CIT;SUZ12;HDGF;CTCF;EED;WIZ;CTBP1;LCOR;PHF1;AHR;SMAD4;RORA;SMAD3;PER1
prerank,miRNA binding (GO:0035198),0.6013052029212453,1.3262793526002274,0.18433734939759036,1.0,1.0,17/30,18.91%,ZC3H7A;AGO2;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,methyl-CpG binding (GO:0008327),0.6223239558372896,1.3229406374416326,0.20287958115183247,1.0,1.0,4/22,11.67%,UHRF1;MBD1;CXXC5;ERH
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4603084805534525,-1.3205704373562293,0.12589928057553956,0.5602160182118231,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4603084805534525,-1.3205704373562293,0.12589928057553956,0.5602160182118231,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,histone methyltransferase activity (GO:0042054),0.5966257859754784,1.3157370695595467,0.2009400705052879,1.0,1.0,5/32,7.48%,EZH2;KMT5A;SUZ12;EED;SETD2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.48082058807015515,-1.3154000805026578,0.1494661921708185,0.5627834166074052,1.0,8/14,28.39%,SPOCK1;TIMP3;SPOCK2;SPOCK3;BST2;TIMP2;LXN;TIMP4
prerank,double-stranded DNA binding (GO:0003690),0.5508511174624888,1.3127187474593804,0.001,1.0,1.0,77/531,10.49%,NEIL3;RAD51AP1;E2F7;E2F8;UHRF1;EN1;RAD51B;E2F2;RAD51;GLI2;TCFL5;GLI3;DDX11;RAD51AP2;HMGB2;E2F1;FOXE1;TERF1;DMC1;MND1;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;RBBP8;HDGF;E2F3;NFE2;TFCP2L1;MSH3;MBD1;HIVEP1;CUX1;DHX9;PRKDC;BHLHE41;KLF5;SRF;TCF7L1;MRE11;ELF4;NFIB;KLF13;MAPT;SP8;HOXC4;PSIP1;ELF1;HOXA7;GMEB1;TCF4;MYBL2;RFX2;ELK1;NUCKS1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;HMGB3;CREB5;KLF11;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;NR3C1;HNRNPU
prerank,sequence-specific mRNA binding (GO:1990825),0.6849029609424302,1.311133828943075,0.19610778443113772,1.0,1.0,4/10,13.52%,TYMS;DHX9;FMR1;DHFR
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5643734728922395,1.31016717759134,0.15705128205128205,1.0,1.0,17/60,17.65%,CDKN3;PPM1G;PPM1D;LRRC40;PHLPP2;TAB1;CTDSPL2;PPP3CA;LRRK2;LRRK1;PPP1CC;MTMR3;PTEN;CTDSPL;UBLCP1;PPP3R1;CDC14A
prerank,chloride channel regulator activity (GO:0017081),-0.481606329255047,-1.3093321928498218,0.1590909090909091,0.5686759112518753,1.0,6/14,16.12%,STX8;STX7;SGK1;WNK2;CHRNA7;VAMP8
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.6213646123224632,1.307156754547714,0.2162516382699869,1.0,1.0,9/17,18.80%,LBR;PTGR1;DPYD;PTGR2;SRD5A3;TM7SF2;DHCR7;BLVRB;BDH2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.5248996625290018,-1.303704736510287,0.19155844155844157,0.5722790230004571,1.0,3/10,13.17%,ATXN3;CYLD;YOD1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45817900971181774,-1.3028482727820652,0.16666666666666666,0.5640173531947844,1.0,9/16,37.48%,CLCN7;SLC4A8;SLC1A1;SLC26A2;SLC26A6;CFTR;CLCN6;SLC26A8;SLC12A5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3925564045118718,-1.2990022035249953,0.12429378531073447,0.5635266473019752,1.0,9/28,15.05%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;CHRNA7;GABRG2;GABRG1
prerank,mRNA methyltransferase activity (GO:0008174),-0.48703706475866393,-1.2916621964413157,0.1891025641025641,0.5720948887229409,1.0,6/12,16.23%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;CMTR1
prerank,ankyrin binding (GO:0030506),0.6205165936959451,1.2909073464426113,0.24015748031496062,1.0,1.0,3/19,9.40%,RHAG;SPTB;SLC8A1
prerank,metalloendopeptidase activity (GO:0004222),0.5517366239535378,1.2879315400110873,0.17172774869109947,1.0,1.0,19/76,14.18%,KEL;MMP24;MMP28;MMP25;TRABD2B;MMP14;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;ADAMTS1
prerank,ion channel activity (GO:0005216),-0.3028121497890476,-1.2862290065137396,0.0,0.5760680746686047,1.0,15/80,10.86%,GRIK1;GRIN3A;GABRB1;TRPM7;UNC80;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4;TMEM63B;TRPC1;CHRNA7;GRIA1;TRPM3
prerank,nucleoside-triphosphatase activity (GO:0017111),0.5342923450138282,1.2802097666663033,0.055055055055055056,1.0,1.0,36/248,12.19%,KIF18B;KIF15;KIF20B;KIF14;RAB33B;RHOA;GNG8;ABCA4;CHD1L;DNA2;DHX9;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;SMCHD1;GNAQ;RHOQ;DNM2;TPPP;SRPRA;ABCB10;RAB1A;ATP2B1;DRG1;RND2;RAC1;RRAS;TSR1
prerank,regulatory RNA binding (GO:0061980),0.5696006510402557,1.2780548757669592,0.22595596755504055,1.0,1.0,18/38,18.91%,ZC3H7A;AGO2;DHX9;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5674788946164593,1.276760729740337,0.2336018411967779,1.0,1.0,5/38,9.77%,SERPINB8;SERPINA9;ANXA2;SERPINE1;AGT
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4522204775511729,-1.2679768885305682,0.16165413533834586,0.6037939728658903,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.4522204775511729,-1.2679768885305682,0.16165413533834586,0.6037939728658903,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5570878806508777,1.2663914344222713,0.21218961625282168,1.0,1.0,13/44,16.40%,EZH2;NSD2;KMT5A;EED;SETDB2;SETD3;SETD2;KMT2A;KMT2D;KMT5C;ASH1L;SETD4;SUV39H2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6382451174338489,1.260406023804811,0.2314410480349345,1.0,1.0,1/11,1.82%,AQP1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.5295643695366838,1.2599422843976986,0.005,1.0,1.0,99/597,11.71%,BRCA1;KIF2C;E2F7;E2F8;EN1;E2F2;MCM5;POLA1;GLI2;CDK5RAP2;ORC1;TCFL5;GLI3;DDX11;HMGB2;E2F1;FOXE1;MCM8;CDC45;MCM10;ZNF32;MCM6;SP3;MCM7;MCM2;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CDC6;CTCF;E2F3;NFE2;TFCP2L1;BCOR;HIVEP1;CUX1;DHX9;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;ZW10;KLF13;ZNF568;TBL1XR1;MCM3;SP8;MCM4;HOXC4;TCF7L2;SOX6;ELF1;ORC2;HOXA7;GMEB1;TCF4;PSPC1;MYBL2;RFX2;ELK1;ZBTB2;ORC3;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;SMAD6;ZNF23;BNC2;IRF1;CREB5;KLF11;YAP1;NONO;NFYA;ARID4A;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;MBD4;NR3C1;SFPQ;HNRNPU;TAL1;HNRNPL;XPA;CPSF4;AHR;NKX2-1;TBX18
prerank,peptidoglycan binding (GO:0042834),-0.5052063445229864,-1.2596319574059203,0.19411764705882353,0.6138656710940027,1.0,3/10,15.46%,NOD1;HK1;PGLYRP1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.5655767964948599,1.2584546797481344,0.2228637413394919,1.0,1.0,16/34,21.10%,PNLDC1;ERI2;CNOT1;CNOT6L;ERI1;CNOT6;PAN3;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6541291708249486,1.2573499106109909,0.23309352517985613,1.0,1.0,2/10,2.33%,CDKN2D;CDKN2C
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4509730879549925,-1.255928508792201,0.18874172185430463,0.6133985118181758,1.0,1/15,0.17%,PLA2G4A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6083240765500659,1.2481491673363312,0.2490118577075099,1.0,1.0,4/18,8.46%,ALDH3A1;ALDH8A1;ALDH1A2;ALDH1A1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.49185886184050637,-1.246657491388833,0.18611111111111112,0.6266924907394423,1.0,5/11,19.58%,SLC1A2;SLC6A1;SLC6A11;SLC1A1;SLC6A15
prerank,ATP binding (GO:0005524),0.5225871285988549,1.2386316272498996,0.088,1.0,1.0,52/266,11.79%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3574109521696244,-1.2376874524552566,0.16666666666666666,0.6389334218499503,1.0,8/38,6.00%,PLA2G4A;KIF16B;PLEKHA5;SNX13;WDR45B;TECPR1;SNX3;SNX21
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4064513595497038,-1.2366565076548104,0.19101123595505617,0.6126704762683796,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,serotonin receptor activity (GO:0099589),-0.4064513595497038,-1.2366565076548104,0.19101123595505617,0.6126704762683796,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4064513595497038,-1.2366565076548104,0.19101123595505617,0.6126704762683796,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,protein serine/threonine kinase activity (GO:0004674),0.5207055880038245,1.2361845113480874,0.063,1.0,1.0,100/335,18.82%,PBK;NEK2;MELK;CDK1;TTK;PLK1;MASTL;AURKB;NEK3;CIT;PLK4;HUNK;MAST2;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;MAP3K14;ROCK2;MAP4K2;GSK3B;STK10;NLK;MAPK4;CHEK2;MYLK3;CASK;PRKDC;DYRK3;VRK2;STK3;STK24;NRK;MAP3K1;WNK1;MAP3K20;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;RIOK3;MAP3K4;ROCK1;PIM1;MARK2;CSNK2A2;CDC42BPG;CAMK1D;TGFBR1;RPS6KC1;SRPK1;EIF2AK3;PRKCB;GAK;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;BRD4;CDK19;PRKCE;PKMYT1;PRKD1;PRKCI;PLK2;NRBP1;VRK1;CDK8;STK11;TAOK1;PRKD2;STK39;PASK;ATP23;HIPK3;ATR;WNK3;CDKL4;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;OXSR1;MAP3K8;MAPK14;LIMK2;HIPK1;RIPK1;BRAF;CAMKV
prerank,neuropeptide binding (GO:0042923),-0.425495053465172,-1.2324097000493888,0.20920502092050208,0.6141957831913426,1.0,12/18,52.57%,GPR37;OPRM1;GPR149;SORL1;OPRK1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,CARD domain binding (GO:0050700),-0.4540348505333512,-1.2311239881673057,0.2085889570552147,0.6085799910070884,1.0,4/14,12.06%,CARD16;CASP4;NOD1;IRGM
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5700349758835761,1.2276286821390416,0.2625766871165644,1.0,1.0,3/28,2.75%,TTK;AURKB;AURKA
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5009888396856292,-1.2243674636865385,0.24382716049382716,0.6172667938588571,1.0,5/10,15.05%,GABRA2;GABRA3;GABRA5;GABRG2;GABRG1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5472545571670078,1.224257634036877,0.25442477876106195,1.0,1.0,7/48,12.51%,RHD;RHAG;AQP1;CALHM2;TRPM2;PIEZO1;TRPM4
prerank,protein homodimerization activity (GO:0042803),0.508583763305485,1.2229780267068209,0.027,1.0,1.0,98/590,12.59%,TOP2A;CENPF;KIF20B;ECT2;CIP2A;BARD1;KNSTRN;PON1;GEN1;TERF1;CEP57;RBM44;TRIM37;TRIML2;BMPR1A;DGCR8;CEP43;UPB1;MTHFD1L;FGFR2;STK10;CRPPA;MAPK4;MSH3;CHEK2;ACTN4;KIT;WDR54;DCK;TPM4;BHLHE41;ADD2;SNX1;LHPP;SRF;BLM;GSS;DPYD;PDLIM4;NUDT5;XDH;PDXK;EXD1;SOX6;TPR;PML;FMR1;ATG7;PDGFRA;TXN;HPGDS;SPPL2B;ZBTB7B;SH3GLB1;HSPB6;FBLN5;ZHX2;DARS2;RNF40;LRRK2;GOLGA5;SMCHD1;TYR;CPQ;MTMR1;DSCAML1;CDA;TPPP;ABCB10;NPR3;AGXT;IKBKG;KMT2A;TKT;SRGAP2;MYO9B;TARS2;SFPQ;BOK;RBPMS2;XPA;PRPS1L1;PRPS1;AHR;CLCN1;TERF2;TBX18;HOGA1;ENPP1;ZHX3;APPL2;ACHE;ASMT;MSH6;GYG1;CPOX;TRIM6;SMAD4
prerank,PDZ domain binding (GO:0030165),0.5260762410916051,1.2204511564166032,0.24546424759871932,1.0,1.0,9/61,10.74%,KIF14;CIT;ATP2B4;PDZK1;TGFBR3;CRIM1;LLGL2;ERC1;ATP2B1
prerank,3'-5' exonuclease activity (GO:0008408),0.5365895101169356,1.2191034273459265,0.25727069351230425,1.0,1.0,20/45,21.21%,PNLDC1;ERI2;RAD1;CNOT6L;MRE11;POLD1;EXD1;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;RAD50;XRN2;PAN2;DIS3;TRIR
prerank,MAP kinase kinase activity (GO:0004708),-0.4371984756681093,-1.2166360969351244,0.2277580071174377,0.6289445159370197,1.0,4/15,3.76%,MAPK10;MAP2K6;PAK3;MAP2K5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.41843572756307407,-1.216311224401191,0.2037735849056604,0.6211747755891888,1.0,9/16,45.75%,PIR;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,voltage-gated sodium channel activity (GO:0005248),-0.38791030044982805,-1.2161094577807965,0.20920502092050208,0.6134315710406317,1.0,6/22,14.97%,HCN1;SCN1A;SCN9A;SCN3A;SCN8A;SCN1B
prerank,carboxy-lyase activity (GO:0016831),0.5753497376528367,1.2150808664401054,0.2702702702702703,1.0,1.0,2/23,3.64%,ACMSD;GGCX
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5899942445963741,1.2149657625092252,0.2743243243243243,1.0,1.0,1/18,0.69%,BIRC5
prerank,lipase activator activity (GO:0060229),0.6390971464539521,1.2149419181895638,0.2822822822822823,1.0,1.0,4/10,15.31%,ARHGAP6;PDPK1;BTK;SRC
prerank,leak channel activity (GO:0022840),0.5943891736721063,1.214232695572152,0.2732166890982503,1.0,1.0,4/18,12.52%,RHAG;KCNK2;KCNK12;KCNK6
prerank,protein heterodimerization activity (GO:0046982),0.5062096760527162,1.2112279049146144,0.15461847389558234,1.0,1.0,35/178,16.54%,TOP2A;BARD1;SAE1;SMC1A;AURKA;SMC3;TPM4;BHLHE41;ADD2;SNX1;BMP6;TCF4;FMR1;SIM1;ZHX2;BDKRB2;IKBKG;CYBB;NR4A2;BOK;GTF2A1;AHR;ZHX3;MICU1;NR4A1;ITGB1;ARNT;VAPA;KCNB2;FXR1;ADD1;TP53;GABBR2;METTL3;ARNT2
prerank,death receptor binding (GO:0005123),0.5918885005131186,1.2111713131681683,0.2920592193808883,1.0,1.0,8/15,23.25%,FADD;CASP8AP2;EDA;NGF;RIPK1;FEM1B;DAB2IP;BID
prerank,calcium-release channel activity (GO:0015278),0.5800797160720494,1.2077141357462324,0.26788036410923277,1.0,1.0,8/17,16.37%,ITPR1;RASA3;TRPA1;TPCN1;TRPM2;ITPR3;PKD2;TPCN2
prerank,adenyl ribonucleotide binding (GO:0032559),0.5088068776669773,1.2058446241168632,0.104,1.0,1.0,56/291,11.79%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;SLC19A1;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MPPED2;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;MIEF1;TGFBR1;HNRNPU;RAPGEF4;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5537564549470184,1.20414422958909,0.28053204353083433,1.0,1.0,9/31,14.63%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,syntaxin binding (GO:0019905),-0.30773631206738417,-1.203968657768388,0.11627906976744186,0.6348384148628512,1.0,25/61,20.68%,UNC13B;STX8;STXBP5L;SNAP47;NAPG;SYT1;STX7;STX6;SYNPR;VPS11;SNPH;ABL1;SNAP29;SYT12;CPLX1;VAMP8;VAMP3;SNAP25;SYT10;SYPL1;RAB11A;SYT6;VPS52;SYT2;VAMP1
prerank,titin binding (GO:0031432),-0.4436932198886562,-1.1959841698380191,0.2621951219512195,0.6459210083360996,1.0,2/13,2.16%,CAMK2D;CALM1
prerank,U6 snRNA binding (GO:0017070),0.5925947228426033,1.192876824540911,0.27350427350427353,1.0,1.0,8/14,18.88%,LSM3;DDX39B;TUT1;LSM2;LSM7;LSM4;PRPF4;LARP7
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.5413815496234939,1.191097399620571,0.278436018957346,1.0,1.0,9/34,14.63%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.40995157435443297,-1.1910869346972888,0.22807017543859648,0.65060679850736,1.0,10/19,21.39%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;GABRG2;GABRG1;GRIK2;GRID1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5570359009587369,1.191080398821727,0.2797858099062918,1.0,1.0,6/18,13.91%,ANXA2;RAB10;ANXA1;PDLIM5;BAIAP2L1;TMOD3
prerank,MHC protein binding (GO:0042287),-0.3983118716301236,-1.1895857037552475,0.24017467248908297,0.6459063525867677,1.0,9/20,29.48%,TAPBP;DERL1;ATP5F1A;CD81;ATP5F1B;TAP2;TUBB4B;CD74;ABCB9
prerank,pseudouridine synthase activity (GO:0009982),-0.43435993972342096,-1.1881379960953353,0.24161073825503357,0.6417527159371742,1.0,11/13,43.86%,PUS10;TRUB1;DKC1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,histone acetyltransferase activity (GO:0004402),0.5455700476261336,1.1853416614645187,0.2946859903381642,1.0,1.0,13/30,18.37%,BRCA2;HAT1;EPC2;ARRB1;SRCAP;EPC1;MCM3AP;TADA2A;BAZ1A;KAT6A;TAF10;NAA60;NAA40
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5477485107630096,1.1848315489116226,0.29295426452410384,1.0,1.0,6/27,10.74%,AQP1;ATP2B4;ITPR1;MAGT1;CNNM4;ATP2B1
prerank,insulin-like growth factor binding (GO:0005520),-0.4192916089911012,-1.1841104129292033,0.24814814814814815,0.6434436301515657,1.0,5/15,13.81%,ITGA6;INSR;ITGB4;IGFBP4;IGF2R
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5429821763272267,1.1822950914349317,0.2993788819875776,1.0,1.0,12/28,24.18%,FADD;TRIM37;CASP8AP2;EDA;RIPK1;TRAF6;TRAF2;FEM1B;TRAF4;DAB2IP;BID;BABAM2
prerank,lysophospholipase activity (GO:0004622),-0.39240798228415935,-1.1776405630838052,0.2629310344827586,0.6517801021236926,1.0,7/20,14.75%,PLA2G4A;ABHD12;ABHD16A;PNPLA6;LYPLA1;GDPD3;GDPD1
prerank,poly-purine tract binding (GO:0070717),0.5489104602272723,1.1759045250039963,0.32169576059850374,1.0,1.0,15/27,16.10%,PABPC4;PATL1;KHDRBS1;FMR1;RBMS2;HNRNPU;ATXN1;RBMS3;LARP4;DAZAP1;RBMS1;PABPC1;ZC3H14;DDX1;PNPT1
prerank,SUMO binding (GO:0032183),0.5847220741966144,1.1736606735387718,0.29402985074626864,1.0,1.0,8/13,23.70%,CASP8AP2;SERBP1;PML;HERC2;SIMC1;RNF111;UBA2;USP25
prerank,endonuclease activity (GO:0004519),0.5144315213109778,1.1731952328003348,0.2912513842746401,1.0,1.0,5/49,5.31%,ANKLE1;ZRANB3;AGO2;ERCC4;MRE11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.286554874825673,-1.1711355767889378,0.2125,0.660358549844612,1.0,25/57,25.19%,COX4I1;COX5A;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFB6;COX8A;NDUFB10;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6003693504565479,1.1705849051058401,0.3125,1.0,1.0,5/11,12.12%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3
prerank,transcription cis-regulatory region binding (GO:0000976),0.48940316458703015,1.169620206718558,0.103,1.0,1.0,84/406,16.40%,BRCA1;E2F7;E2F8;UHRF1;E2F2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;ZBTB8A;ZFP69;RB1;SP3;SETX;ZFP41;ETV6;TWIST2;TEAD1;AGO2;CTCF;E2F3;TFDP1;NFE2;BCOR;RFXAP;ACTN4;CUX1;NFIL3;ZNF568;TBL1XR1;TCF7L2;SOX6;GRHL2;PSPC1;ELK1;SIM1;ZBTB7B;FOXO3;LMX1B;SMAD6;BNC2;IRF1;ZFP90;KLF11;YAP1;NONO;NFYA;ARID4A;PLAGL1;LONP1;ZBTB20;HMGB1;NR3C1;SFPQ;TAL1;HNRNPL;HDAC1;AHR;NKX2-1;TBX18;STOX1;TAF4;KMT2D;SMAD4;ATF5;RORA;TWIST1;POU2F2;YY1;FOXK2;FOXM1;SMAD3;ARNT;PER1;RBAK;DR1;ATF1;NFKB1;TP53;DRAP1;PURA;ZNF25;SUV39H2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.48820397097180934,1.1695597678293888,0.132,1.0,1.0,67/346,14.63%,DTL;BRCA1;NEURL1B;UHRF1;BARD1;UBE2T;UBE2C;UBE2S;RFWD3;RNF168;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;BCOR;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;PML;UBE2N;RNFT2;PRPF19;CUL5;MEX3C;RNF31;RC3H2;UBR5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;SH3RF1;CUL4B;OBI1;RNF145;HERC2;TRIM63;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;FBXO25;XIAP;RC3H1;HLTF;TRIM5;RNF114;UBE2QL1;ZNRF1;ZFP91;BIRC6
prerank,lipid phosphatase activity (GO:0042577),-0.42794595553288206,-1.1657098434760595,0.2923076923076923,0.666165803635394,1.0,5/14,21.13%,PLPPR1;PLPP3;INPP5K;EPHX2;PLPPR4
prerank,protein tyrosine kinase activity (GO:0004713),0.49037425602215146,1.1652733870155327,0.2589928057553957,1.0,1.0,13/108,7.60%,MELK;TTK;WEE1;MATK;DYRK1A;STYK1;BAZ1B;FGFR4;FGFR2;KIT;MUSK;PDGFRA;EPHA4
prerank,sequence-specific DNA binding (GO:0043565),0.4870580671016939,1.1625567552244587,0.08,1.0,1.0,98/590,14.42%,E2F7;NR2E3;E2F8;UHRF1;EN1;PIF1;E2F2;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;TERF1;CBFB;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;HNRNPD;NFE2;STN1;TFCP2L1;MBD1;HIVEP1;CUX1;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;KLF13;MAPT;MAEL;SP8;GZF1;HOXC4;TCF7L2;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;RFX2;ELK1;POU2F1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;KDM2B;PLAGL2;ZNF23;CREB5;KLF11;ZIC5;LONP1;ZBTB20;KMT2A;HOXB6;MEOX2;NR4A2;NR3C1;CXXC5;HNRNPU;XPA;CPSF4;AHR;TERF2;ERH;TBX18;RBPJ;NR4A1;ZIC4;SMAD4;HDAC2;ATF5;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;SMG6;YY1;FOXK2;SMAD3;ARNT
prerank,metal ion binding (GO:0046872),0.48598123814608135,1.1607628176257128,0.1,1.0,1.0,70/477,12.90%,TOP2A;EFCAB11;MELK;PIF1;PLK1;PON1;FIGNL1;GEN1;CDH15;MAST2;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;NLK;ITPR1;PAM;IDH3A;TDP2;TPM4;DYRK3;PRNP;GSS;HPRT1;CDH4;NUDT5;STK3;ANXA3;PDXK;RAP2A;ANXA5;NDUFAB1;CABCOCO1;MAP3K20;ENPP2;HPGDS;PPP3CA;CDC42BPA;ENPP3;LRRK2;FKBP9;PGM1;ATP2A2;TPPP;SLC8A1;PPA1;MARK2;TKT;EYA2;CDC42BPG;TRPM2;CALM2;SRPK1;ANXA1;ENPP1;CALB1;MICU1;ITPR3;MSH6;TRPM4;POSTN;SIK2;MEX3B;DUT;MAN1C1
prerank,acetylation-dependent protein binding (GO:0140033),0.5464070912366084,1.1605868557396801,0.30394736842105263,1.0,1.0,9/20,20.69%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.5464070912366084,1.1605868557396801,0.30394736842105263,1.0,1.0,9/20,20.69%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,sodium channel activity (GO:0005272),-0.3111953864328616,-1.1587303099866222,0.21768707482993196,0.6752928957501557,1.0,10/37,21.29%,GRIK1;HCN1;SCN1A;GRIK4;SCN9A;SCN3A;SCN8A;SCN1B;KCNK1;GRIK2
prerank,5'-nucleotidase activity (GO:0008253),-0.43511684679689594,-1.1575826991138636,0.29225352112676056,0.6702944354593802,1.0,6/13,30.04%,NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5583460589608291,1.155432362302125,0.30248618784530384,1.0,1.0,2/15,10.19%,GPR171;P2RY1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5133628184422836,1.1523661664796487,0.3247058823529412,1.0,1.0,8/34,13.08%,RACGAP1;IQGAP2;GBF1;ZFYVE16;ZFYVE1;MAPKAP1;CYTH3;BTK
prerank,GTPase regulator activity (GO:0030695),0.4821138890515848,1.1520964055596483,0.2246740220661986,1.0,1.0,41/212,10.55%,IQGAP3;ECT2;RACGAP1;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RGS12;GPSM2;ARHGAP10;ARHGAP28;ASAP1;DEPDC5;EVI5L;ACAP2;TBC1D25;ARHGAP18;OCRL;STXBP5;TBC1D13;ARRB1;CDC42EP2;TBC1D2B;ASAP2;ARHGAP24;LRRK2;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;CPEB2;TBC1D7;LLGL2;RIC8B;NPRL3;RANGAP1;SRGAP2;MYO9B;ARHGAP35;ERRFI1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3608070133306145,-1.1520211890403744,0.23113207547169812,0.6762599181332078,1.0,6/23,4.87%,KIF16B;PLEKHA5;WDR45B;CLVS1;SNX14;SNX3
prerank,platelet-derived growth factor binding (GO:0048407),-0.4462100486063001,-1.1502215433615306,0.29012345679012347,0.6729657013986534,1.0,4/11,9.22%,COL6A1;PDGFRB;COL5A1;COL1A2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.42306793821645916,-1.1494889370464543,0.2912280701754386,0.6672977453346735,1.0,7/13,20.95%,PIP4K2A;PIP4K2B;PIK3C2B;PIP5K1A;PIK3CD;PIK3CA;PIP4K2C
prerank,metallopeptidase activity (GO:0008237),0.4886694065747697,1.1489423106609353,0.2894736842105263,1.0,1.0,23/113,14.18%,KEL;BMP1;MMP24;MMP28;MMP25;TRABD2B;MMP14;ADAM12;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;PSMD14;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;BRCC3;ADAMTS1
prerank,signal sequence binding (GO:0005048),0.5142436019089539,1.14822870394129,0.31062355658198615,1.0,1.0,4/35,5.14%,KPNA2;KPNA3;BRAP;TNPO1
prerank,cation:chloride symporter activity (GO:0015377),-0.47059084931085804,-1.1478110270886408,0.2932098765432099,0.6640084929724954,1.0,3/10,16.25%,SLC6A1;SLC12A9;SLC12A2
prerank,protein phosphatase 1 binding (GO:0008157),-0.3751463025012936,-1.1436930878258125,0.2597402597402597,0.6664480731566667,1.0,7/21,22.79%,PPP1R16B;SHOC2;PPP1R3B;SH3RF2;PPP1R11;KCNQ1;PPP1R3C
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3891226527664385,-1.1433986542439438,0.28,0.6597148164104157,1.0,17/18,61.13%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,voltage-gated ion channel activity (GO:0005244),-0.43022913483712294,-1.143211260190488,0.2973856209150327,0.6530465007932115,1.0,4/14,9.49%,HCN1;ANO6;GPR89B;GPR89A
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5696558817431258,1.140145361252629,0.33612273361227335,1.0,1.0,7/14,19.60%,RPP40;TSEN34;RPP30;POP1;TSEN2;PRORP;RPP21
prerank,vitamin D receptor binding (GO:0042809),0.5665938427295649,1.1397810822143817,0.33052039381153303,1.0,1.0,5/14,13.63%,MED14;THRAP3;MED30;MED24;MED1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5168347734766587,1.1376509307981395,0.32521315468940315,1.0,1.0,10/29,17.31%,CIT;CDKN2D;CDKN2C;PKIG;SPRED1;CDKN1B;RPTOR;SPRED2;PRKAR2B;PRKAR2A
prerank,semaphorin receptor binding (GO:0030215),-0.3512759543314573,-1.1372918407822166,0.2777777777777778,0.6605854993445697,1.0,17/23,38.74%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;RIT2;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F;SH3BP1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5159251505632245,1.134634870422948,0.33294392523364486,1.0,1.0,14/33,21.10%,PNLDC1;ERI2;CNOT6L;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.482520239262279,1.134582054486431,0.31803628601921025,1.0,1.0,12/69,16.78%,ESCO2;CERS6;CERS5;SOAT1;PORCN;ZDHHC18;SOAT2;ZDHHC15;HHAT;KAT6A;ZDHHC3;ZDHHC21
prerank,E-box binding (GO:0070888),0.5161315870416484,1.1328371407864593,0.36,1.0,1.0,9/34,17.38%,ATOH8;ZEB1;BHLHE41;TCF4;TAL1;AHR;TWIST1;PER1;TFAP4
prerank,single-stranded RNA binding (GO:0003727),0.49683011482978484,1.1324716827953267,0.336322869955157,1.0,1.0,12/43,15.52%,DDX11;ILF3;AGO2;DHX9;HNRNPA1;EIF4H;FMR1;LONP1;HNRNPU;STRBP;AQR;FXR1
prerank,dynactin binding (GO:0034452),0.5715315983711331,1.1324226731973364,0.3323615160349854,1.0,1.0,3/12,6.63%,GSK3B;MAPT;BICD2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5551670083868168,1.1299333073026565,0.3305439330543933,1.0,1.0,6/14,16.13%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,tau protein binding (GO:0048156),-0.30655557159842045,-1.129701667180682,0.27049180327868855,0.6711151278740847,1.0,12/40,7.83%,EP300;MARK3;HSP90AB1;ACTB;APOE;BIN1;TAOK2;BRSK1;PRKAA1;PPP2CB;LGMN;MAP1A
prerank,ion gated channel activity (GO:0022839),-0.3623117309988259,-1.1296083138519903,0.28421052631578947,0.6642328604115693,1.0,9/24,15.73%,ANO3;ANO6;ANO1;ANO10;TMEM63B;ANO4;KCNT1;TTYH2;TTYH3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5778063760355743,1.126933307018836,0.3230293663060278,1.0,1.0,3/10,8.79%,BRCA2;HAT1;MSL3
prerank,calcium-activated potassium channel activity (GO:0015269),0.5747344706402694,1.1255215282247464,0.34175334323922735,1.0,1.0,4/11,14.77%,KCNN4;KCNMB2;KCNMB3;KCNMB4
prerank,leucine zipper domain binding (GO:0043522),0.5812365127458509,1.1230326386656664,0.3446153846153846,1.0,1.0,3/10,11.75%,PMF1;ERC1;MRTFA
prerank,nucleotidase activity (GO:0008252),-0.40135828865249323,-1.1226393061797226,0.3161764705882353,0.6733887751661823,1.0,7/15,30.04%,BPNT2;NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.40342856256589454,-1.121635073055899,0.33204633204633205,0.6684524482142479,1.0,10/15,55.25%,CCR9;CMKLR1;CX3CR1;CCR5;CCR2;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,copper ion binding (GO:0005507),0.48627564212229135,1.119674768991814,0.36210762331838564,1.0,1.0,10/42,17.78%,LOXL3;LOXL2;PAM;PRNP;SOD3;TYR;COA6;TP53;CCS;LACC1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5426937360907992,1.118091064824634,0.34652114597544337,1.0,1.0,6/16,16.13%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4019653461204305,-1.117960922200395,0.28619528619528617,0.6705359436998204,1.0,6/14,37.86%,KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34119159166989543,-1.1163811326519206,0.2916666666666667,0.6669786656408271,1.0,8/27,19.27%,SLC22A8;ANO1;SLC22A6;SLC5A5;SLC26A11;SLC25A11;LRRC8A;SLC26A2
prerank,insulin-like growth factor I binding (GO:0031994),-0.4117448389000941,-1.1145193344767121,0.31986531986531985,0.6644703017405057,1.0,4/13,12.36%,ITGA6;INSR;ITGB4;IGFBP4
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5491605556282445,1.1122368657686676,0.35935397039030953,1.0,1.0,3/15,8.46%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.44499113401101,-1.1116194792516827,0.32926829268292684,0.6645209862069452,1.0,5/11,37.86%,KCNJ3;KCNQ1;KCNJ8;KCNE4;KCNH2
prerank,neuropeptide receptor activity (GO:0008188),-0.3305607930902893,-1.109719268955868,0.26666666666666666,0.662296123745559,1.0,5/29,10.55%,SORCS3;SORCS1;GPR37;OPRM1;HCRTR2
prerank,symporter activity (GO:0015293),-0.4506025644319209,-1.1092112662922293,0.3261538461538461,0.6568106072597197,1.0,3/10,23.34%,SLC5A6;SLC5A5;MFSD2A
prerank,thyroid hormone receptor binding (GO:0046966),0.5094677759589882,1.1085860085164612,0.3567901234567901,1.0,1.0,12/28,20.06%,TRIP6;THRAP3;MED30;MED24;ZNHIT3;TRIP12;MED1;JMJD1C;BRD8;ARID5A;MED16;GTF2B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5557752421008785,1.1031329912744727,0.34763948497854075,1.0,1.0,5/12,10.90%,TENT2;TENT4A;TUT1;PAPOLB;TENT5D
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.4620227720312656,1.1031147109249566,0.228,1.0,1.0,83/431,13.71%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;RANBP17;TUBB6;HASPIN;MAST2;TUBA1C;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;TUBE1;RTEL1;RHOA;MTHFD1L;MAP4K2;GCK;NLK;RAB10;CARS2;RRAD;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;RHOT1;STK3;MYH10;PDXK;RAP2A;ATL2;WNK1;MAP3K20;ATL3;RAB22A;CDC42BPA;RAB29;RASEF;TUBD1;DARS2;LRRK2;GUK1;ABCF3;RHOQ;DNM2;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;DRG1;SRPK1;PRPS1L1;PRPS1;TWF1;RND2;RAC1;ABCA1;ENPP1;RRAS;SEPHS1;TSR1;MSH6;SIK2;BTK;PRKCI;DRG2;ARF4;MVK
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5266864943292844,1.102265574309902,0.35714285714285715,1.0,1.0,7/20,14.72%,MAGI3;CASK;GUK1;DTYMK;TJP2;DLG1;AK7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.45046690156019065,-1.1019519022930557,0.37846153846153846,0.6666333883682336,1.0,5/10,18.25%,PIK3R3;PIK3C2B;ATM;PIK3CD;PIK3CA
prerank,actinin binding (GO:0042805),0.5206999945260472,1.0988070643475012,0.3606770833333333,1.0,1.0,8/21,15.73%,CSRP2;PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2;CSRP3;NFKB1
prerank,fibroblast growth factor binding (GO:0017134),0.5222923701665313,1.0984531884779234,0.35446313065976714,1.0,1.0,4/21,9.43%,CEP57;FGFR4;FGFR2;FGFRL1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5660534548399339,1.093586806082482,0.37409024745269287,1.0,1.0,4/12,18.79%,AIFM2;NQO1;CRYZL1;DHRS4
prerank,actin binding (GO:0003779),0.4592642667050159,1.0931525434792142,0.36016096579476864,1.0,1.0,47/170,17.59%,KIF18A;GAS2L3;ANLN;VASH2;IQGAP2;SYNE2;MACF1;SPTB;PARVA;ACTN4;SPEF1;ADD2;SLC6A2;MAPT;PDLIM4;SSH2;MYH10;MICAL3;MLPH;CXCR4;PHACTR1;LRRK2;EPS8L1;EMD;MYO9B;HNRNPU;SMTN;TWF1;CAPZA1;EZR;PHACTR2;MRTFA;PDLIM5;DMTN;SYNPO2;PRKCE;TLN2;ITGB1;ADD1;LCP1;DBN1;PLEKHH2;TNNT3;VPS16;COBL;SHROOM2;TRPV4
prerank,hormone receptor binding (GO:0051427),-0.387289764757638,-1.0890605401105966,0.35855263157894735,0.6904799998261539,1.0,5/14,27.51%,SOCS2;JAK2;PTHLH;ADCYAP1;JAK1
prerank,chloride channel inhibitor activity (GO:0019869),-0.45152302256818977,-1.0863548413560007,0.3819241982507289,0.6903957116524122,1.0,3/10,5.02%,STX8;STX7;WNK2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.39865399224598363,-1.0835942665243203,0.3763837638376384,0.6906837282356859,1.0,6/13,20.56%,IL1R1;PDGFRB;PDGFD;VEGFA;VEGFD;ITGB3
prerank,vinculin binding (GO:0017166),0.556105198779891,1.0829501689449528,0.3887240356083086,1.0,1.0,4/11,11.42%,CTNNA1;SORBS3;TLN1;SYNM
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3869083874171878,-1.079250727034684,0.32170542635658916,0.6947518592020792,1.0,3/15,4.87%,PLA2G4A;PLEKHA5;SNX3
prerank,pre-mRNA binding (GO:0036002),0.49677656286262917,1.0792278184815685,0.3915737298636927,1.0,1.0,8/28,13.46%,TRA2B;HNRNPA1;SLBP;ERI1;CELF2;HNRNPU;HNRNPL;RBM4
prerank,ATPase activator activity (GO:0001671),-0.3593936863112839,-1.0792003872326978,0.3623853211009174,0.6884589136677871,1.0,5/20,9.08%,ATP1B1;DNAJC24;DNAJC19;DNAJA1;ATP1B3
prerank,GTPase activator activity (GO:0005096),0.4510273714197521,1.0788204354307245,0.311,1.0,1.0,61/313,11.25%,IQGAP3;ECT2;RACGAP1;PCP2;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RANGRF;DENND2C;ARHGAP10;FNIP1;ARHGAP28;ASAP1;RCBTB2;DEPDC5;EVI5L;MYCBP2;ACAP2;TBC1D25;ARHGAP18;OCRL;DENND4C;STXBP5;TBC1D13;DNMBP;FGD4;EIF2B1;DENND2A;ARRB1;CDC42EP2;VAV2;TBC1D2B;FGD1;ASAP2;ARHGAP24;ANKRD27;LRRK2;RAB3IL1;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;TBC1D7;FARP1;LLGL2;EPS8L1;RIC8B;NPRL3;RANGAP1;DENND5A;SRGAP2;MYO9B;HERC2;ARHGAP35;ERRFI1;CYTH3;FGD6;RAPGEF4;ARHGEF18
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4969886318690543,1.0787711407410816,0.3957345971563981,1.0,1.0,5/27,7.46%,PRIM1;POLR1A;PRIMPOL;POLR1B;POLR2A
prerank,LRR domain binding (GO:0030275),0.5267676794904619,1.0779655577526044,0.3788732394366197,1.0,1.0,4/14,11.75%,PMF1;ROBO1;ERC1;MRTFA
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5293863832720791,1.0722114782076766,0.38945827232796487,1.0,1.0,2/14,5.88%,RDH11;RDH12
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2725554422437294,-1.0715634055382746,0.38461538461538464,0.6997246339278291,1.0,19/56,18.98%,NRG3;GRB14;GAS6;SQSTM1;PIK3R1;DUSP3;SOCS5;TOB1;IRS1;FLT3LG;ANGPT2;PTPN14;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,mRNA 3'-UTR binding (GO:0003730),0.4505227492994546,1.0682280450549346,0.39539748953974896,1.0,1.0,26/79,15.81%,ILF3;PABPC4;LARP4B;SERBP1;FMR1;YBX3;RBMS2;CELF2;LARP1;TUT1;RNF40;CPEB2;PUM2;HNRNPU;RBMS3;MEX3D;RBM4;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;SECISBP2;HNRNPA2B1;FXR1;TP53
prerank,phosphatase binding (GO:0019902),0.448457171279664,1.0660667014827683,0.4026503567787971,1.0,1.0,30/105,18.66%,NEK2;CEP192;MAST2;ANAPC7;KCNN4;CDC27;PDLIM4;RPA2;ANK1;WNK1;MTMR9;EIF2AK3;AP3B1;CHCHD3;DLG1;SPRED1;CDKN1B;SMAD3;MTMR3;TP53;ANAPC5;PPP3R1;SIRPA;PPME1;MVP;SMAD2;TERF2IP;BAD;MAPK14;KIFAP3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5409863642454429,1.0654460495026872,0.40896358543417366,1.0,1.0,3/13,8.46%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,adenylate cyclase binding (GO:0008179),-0.44240729242749705,-1.0540517817362642,0.39779005524861877,0.7342393017631201,1.0,3/10,6.66%,CALM1;AKAP6;CAP1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5341953898990843,1.0534161051993,0.4148471615720524,1.0,1.0,3/12,8.16%,AGO2;EIF4E;LARP1
prerank,Notch binding (GO:0005112),-0.33167634155505216,-1.053139018715246,0.37104072398190047,0.7296669307785676,1.0,9/22,20.56%,DNER;SNED1;JAG1;KCTD10;DTX1;JAG2;NOTCH4;SNW1;HIF1AN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5412131896181509,1.0528941167040253,0.4199395770392749,1.0,1.0,3/10,17.78%,ADA;CDA;LACC1
prerank,protein tyrosine kinase binding (GO:1990782),-0.25184190849018157,-1.051359574124289,0.3333333333333333,0.7275512257970784,1.0,24/71,18.98%,NRG3;ACVR1;GRB14;BMPR2;NEDD9;GAS6;SQSTM1;CDH5;DUSP3;DUSP22;SOCS5;TOB1;FLT3LG;ANGPT2;GRM5;PTPN14;PTPN11;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,calcium channel regulator activity (GO:0005246),-0.30209684270005577,-1.049299509229012,0.3384615384615385,0.7255532168763155,1.0,13/37,21.15%,PRKG1;CALM1;FKBP1A;SGK1;CACNG7;NRXN1;CACNG4;SLC30A1;SRI;CACNG8;INAFM1;REM1;PACSIN3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.436790497328005,1.0416992115971442,0.342,1.0,1.0,128/731,15.86%,E2F7;NR2E3;E2F8;UHRF1;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;HMGB2;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SMAD4;ZNF394;ZNF496;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,ubiquitin protein ligase activity (GO:0061630),0.43361576965882226,1.0385906706163837,0.445,1.0,1.0,47/228,15.64%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;UBOX5;TRIM63;SMURF2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,channel activity (GO:0015267),0.4655184190331405,1.0377172845012292,0.41968325791855204,1.0,1.0,6/41,12.03%,AQP1;TRPA1;PDPN;MCUB;SLC14A1;CHRNB1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.29119380904271736,-1.0360091642580942,0.38461538461538464,0.7505828727532745,1.0,13/37,19.61%,CACNA2D1;CACNG7;CACNA1B;CACNG4;OPRM1;NCS1;CACNG2;CACNB2;CACNG3;CACNG8;CACNB1;CACHD1;CACNA2D2
prerank,growth factor receptor binding (GO:0070851),-0.2188701418770361,-1.0350390762868011,0.5416666666666666,0.7462377008934672,1.0,24/95,20.56%,IL1R1;PSEN1;VEGFC;SNX4;PDGFRB;PIBF1;FGF2;NCSTN;ERBB4;TGFA;FGF1;GRB2;PDGFD;SNX2;SDCBP;HIP1;SHC1;VEGFA;VEGFB;LINGO1;VEGFD;IL1RAP;HBEGF;ITGB3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.42890934078907794,1.033977370103817,0.438,1.0,1.0,42/269,11.39%,BRCA1;CCNB1;UBE2T;UBE2C;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;DDRGK1;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;STAM;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;PARP9;HERC2;UBOX5;ARRDC1;BAG5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5172659390089411,1.031997367538193,0.4182076813655761,1.0,1.0,5/12,18.32%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,Hsp70 protein binding (GO:0030544),-0.2915251016801725,-1.0318344555059134,0.36416184971098264,0.7474396625393278,1.0,12/31,24.85%,PRKN;DNAJA1;GPR37;PACRG;STUB1;DNAJC18;METTL21A;PPEF2;DNAJB12;RPS3;TSC1;HIKESHI
prerank,ribonuclease P activity (GO:0004526),0.5349745511817228,1.031392495994625,0.4365781710914454,1.0,1.0,5/11,19.60%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,CoA hydrolase activity (GO:0016289),-0.3554269579119984,-1.026510676343344,0.40559440559440557,0.7544598907872516,1.0,6/16,25.11%,ACOT11;NUDT7;ACOT7;ACOT13;HIBCH;ACOT6
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5179863812639843,1.026212655292508,0.4481203007518797,1.0,1.0,2/12,7.71%,CTSE;SPPL2B
prerank,myosin binding (GO:0017022),0.44601071284350885,1.0260155498621937,0.46871569703622395,1.0,1.0,10/55,9.28%,TRIOBP;TRAK1;RHOA;KIRREL1;RAB10;STXBP5;MLPH;CXCR4;SPATA6;LLGL2
prerank,phospholipase activator activity (GO:0016004),0.522713047827202,1.0213422200633557,0.4374057315233786,1.0,1.0,4/10,15.31%,ARHGAP6;PDPK1;BTK;SRC
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4303188104909392,1.020879477443308,0.47289156626506024,1.0,1.0,40/188,15.81%,BRCA1;CDK5RAP2;HMGB2;CTCF;LIN54;BCOR;DHX9;ZNF568;TBL1XR1;TCF7L2;SOX6;PSPC1;ELK1;FOXO3;SMAD6;BNC2;IRF1;KLF11;YAP1;NONO;NFYA;ARID4A;ZBTB20;HMGB1;SFPQ;TAL1;HNRNPL;AHR;NKX2-1;TBX18;KMT2D;SMAD4;ATF5;POU2F2;YY1;FOXK2;SMAD3;PER1;NFKB1;TP53
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3094522712918382,-1.0169662601333096,0.37967914438502676,0.7722993823188857,1.0,7/25,13.03%,PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,phosphatase activator activity (GO:0019211),0.5118988104449059,1.0157786813287377,0.46013986013986014,1.0,1.0,6/14,20.12%,FRS2;PPP2R5C;CALM2;BMP2;PPP2R5B;PHACTR4
prerank,ubiquitin-specific protease binding (GO:1990381),-0.32995129319639827,-1.015630250776956,0.41732283464566927,0.7695307541137407,1.0,10/19,24.62%,PRKN;DERL1;SELENOS;RHBDD2;SART3;SYVN1;PARK7;RAD23A;CHMP3;SPATA2
prerank,beta-tubulin binding (GO:0048487),0.4554244148712568,1.0149840453569892,0.4644149577804584,1.0,1.0,8/31,17.59%,RACGAP1;SMC3;UXT;EMD;TAOK1;EML4;TBCD;TRPV4
prerank,chemokine binding (GO:0019956),0.4601234796093722,1.0149313406614662,0.4499396863691194,1.0,1.0,6/30,14.99%,PLP2;PDPN;CXCR4;HMGB1;ITGB1;ITGAV
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.41856270515179356,-1.0144333669449415,0.44285714285714284,0.7662415044058205,1.0,6/10,26.06%,DPP9;DPP8;PRCP;DPP10;FAP;DPP3
prerank,hexosaminidase activity (GO:0015929),0.5212890754501267,1.0134583608343222,0.443001443001443,1.0,1.0,2/12,3.28%,SPAM1;HYAL1
prerank,fatty acid synthase activity (GO:0004312),-0.42154542360480074,-1.013096653816134,0.4411764705882353,0.763181492198014,1.0,6/10,34.55%,ELOVL7;ELOVL6;CBR4;ELOVL1;OXSM;MCAT
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44316624877237326,1.0128438560052053,0.47830802603036876,1.0,1.0,14/53,14.85%,AIFM2;DPYD;MTHFR;XDH;MICAL3;AGPS;QSOX1;NOX4;KMO;SQOR;CYBB;GFER;ACADL;CYB5R1
prerank,bHLH transcription factor binding (GO:0043425),0.48426578719271984,1.0126007250870226,0.4182058047493404,1.0,1.0,4/19,14.33%,FHL2;BHLHE41;TWIST1;SMAD3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42247737461134915,1.0111793432634808,0.44,1.0,1.0,145/830,15.86%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;E2F1;FOXE1;ATOH8;ZBTB8A;ZFP69;ZNF32;RB1;PBX3;SP3;HOXC5;ZFP41;ETV6;TWIST2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;TFDP1;NFE2;TFCP2L1;RFXAP;ACTN4;ZNF260;NFIA;HIVEP1;CUX1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;SIM1;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;IRF1;CREB5;ZFP90;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;GTF2A1;ZNF585B;ZNF585A;CHD2;HDAC1;NKX2-1;KLF9;TBX18;STOX1;RBPJ;NR4A1;ZIC4;SMAD4;ZNF394;ATF5;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;RBAK;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,histone deacetylase activity (GO:0004407),0.4919729329429647,1.0108510260972883,0.45136186770428016,1.0,1.0,9/19,22.41%,MIER1;MIER3;HDAC8;HDAC1;HDAC2;HDAC4;SIRT2;SIRT3;MIER2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.42156518883537686,1.0104488641805818,0.498,1.0,1.0,46/232,15.64%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;TRIM63;SMURF2;NSMCE2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5066699230824077,1.0090799742210725,0.4412191582002903,1.0,1.0,4/11,10.85%,UBE2K;PRPF19;UBR5;UBOX5
prerank,retinoic acid receptor binding (GO:0042974),0.48340583166478046,1.0049023294725115,0.4649243466299862,1.0,1.0,7/17,20.21%,CNOT1;ACTN4;ASXL1;NR4A2;MED1;ARID5A;MED25
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41925679230560275,1.000547729640069,0.5,1.0,1.0,127/730,15.86%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SMAD4;ZNF394;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,FAD binding (GO:0071949),0.4659930861652508,0.9989558490456576,0.47696139476961397,1.0,1.0,6/24,9.81%,MTHFR;MICAL3;AGPS;QSOX1;KMO;SQOR
prerank,death receptor activity (GO:0005035),-0.3989214144569974,-0.9977528245716408,0.49691358024691357,0.793781136489914,1.0,4/11,11.61%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B
prerank,cadherin binding (GO:0045296),0.4156977084855699,0.9940066909986595,0.531,1.0,1.0,65/315,15.31%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CDH15;MACF1;CDH18;CDH24;ANXA2;ZC3HAV1;PARVA;ASAP1;GPRC5A;RAB10;PACSIN2;UBAP2;ARHGAP18;SNX1;SERBP1;MRE11;CDH4;STK24;EIF4H;AFDN;CTNNA1;CNN2;SCRIB;SH3GLB1;LARP1;CORO1B;ABCF3;NCK1;ABI1;EPS8L1;PICALM;EMD;ERC1;MARK2;RAB1A;RANGAP1;TLN1;NDRG1;TWF1;CAPZA1;CRKL;EZR;ANXA1;PDLIM5;TES;WASF2;TJP2;EHD1;BAIAP2L1;CAST;CLIC1;DLG1;TMOD3;ITGB1;CAPG;MPRIP;CLINT1;VAPA;SRC
prerank,tau-protein kinase activity (GO:0050321),0.47043636634226466,0.9916070184829414,0.4635416666666667,1.0,1.0,5/20,9.80%,DYRK1A;ROCK2;GSK3B;ROCK1;MARK2
prerank,disordered domain specific binding (GO:0097718),0.46525708606649185,0.9915638207757226,0.4625322997416021,1.0,1.0,7/23,17.82%,PPIL1;RB1;NUMA1;CALM2;TP53;KCNA1;SMAD2
prerank,exopeptidase activity (GO:0008238),-0.2578736624828183,-0.9886072660633848,0.5172413793103449,0.8106617736775491,1.0,12/50,14.51%,LNPEP;CPE;CTSZ;LAP3;ACE;METAP1D;ENPEP;CTSA;DPP9;DPP8;XPNPEP1;PRCP
prerank,protein phosphatase 2A binding (GO:0051721),0.4562001033565886,0.9884962732333976,0.4648241206030151,1.0,1.0,7/23,17.36%,MASTL;MAPT;ENSA;PTPA;TP53;ANKLE2;PPME1
prerank,P-type ion transporter activity (GO:0015662),0.4988272767497372,0.9871217586038727,0.46647230320699706,1.0,1.0,3/12,10.74%,ATP2B4;ATP2A2;ATP2B1
prerank,nucleosomal DNA binding (GO:0031492),0.4724445721298002,0.985300582300956,0.472258064516129,1.0,1.0,13/21,24.82%,SMARCC1;RBBP4;SMARCA4;HDAC1;HDAC2;MBD3;MBD2;CHD4;ACTL6A;H3-3A;SMARCC2;SMARCB1;HNRNPC
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5066030977885937,0.9839066106960374,0.475482912332838,1.0,1.0,7/12,24.70%,POU2F1;GTF2A1;HDAC1;RUVBL2;GTF2B;H3-3A;RELA
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4086115949782549,0.9833906883501722,0.5415415415415415,1.0,1.0,21/173,10.83%,E2F8;EN1;TCFL5;ZFP69;ETV6;SP2;CTCF;ZEB1;BHLHE41;NFIL3;GZF1;ZBTB2;MXD1;FOXO3;ZFP90;ZBTB25;PLAGL1;ZBTB20;MYPOP;NR3C1;KCNIP3
prerank,nuclear receptor coactivator activity (GO:0030374),0.42678510619074683,0.9817466164888807,0.4961748633879781,1.0,1.0,14/52,13.63%,MED14;ACTN4;THRAP3;CCAR1;MED30;ELK1;CNOT6;MED24;NCOA2;PRKCB;SLC30A9;NCOA7;PPRC1;MED1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.40893073083420783,0.9797819584816985,0.5352112676056338,1.0,1.0,27/147,12.58%,ECT2;PCP2;RANGRF;DENND2C;FNIP1;RCBTB2;MYCBP2;DENND4C;DNMBP;FGD4;EIF2B1;DENND2A;VAV2;FGD1;ANKRD27;RAB3IL1;FARP1;EPS8L1;RIC8B;DENND5A;HERC2;CYTH3;FGD6;RAPGEF4;ARHGEF18;DENND1A;DOCK11
prerank,RNA stem-loop binding (GO:0035613),0.49171732667766177,0.9790004267656596,0.49411764705882355,1.0,1.0,6/12,14.57%,DHX9;MYH10;FMR1;RC3H2;RC3H1;EPRS1
prerank,protein phosphatase binding (GO:0019903),0.41107910254039176,0.9784375576026091,0.5279755849440488,1.0,1.0,27/117,18.66%,NEK2;MASTL;ATP2B4;ANAPC7;KCNN4;CDC27;MAPT;PDLIM4;RPA2;ANK1;MTMR9;EIF2AK3;AP3B1;AKAP11;ENSA;CDKN1B;PTPA;MTMR3;TP53;ANKLE2;ANAPC5;SIRPA;PPME1;MVP;BAD;MAPK14;KIFAP3
prerank,poly(A) binding (GO:0008143),0.4718854940806275,0.9777543214535801,0.4845360824742268,1.0,1.0,10/21,15.88%,PABPC4;KHDRBS1;RBMS2;HNRNPU;RBMS3;LARP4;RBMS1;PABPC1;ZC3H14;DDX1
prerank,GTPase inhibitor activity (GO:0005095),0.4911021943280006,0.9769477669393997,0.4878048780487805,1.0,1.0,4/13,16.56%,IQGAP2;CPEB2;IPO5;TNK2
prerank,small GTPase binding (GO:0031267),0.41121233955794484,0.9763807933031724,0.5496489468405216,1.0,1.0,38/170,13.47%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.23364621039002306,-0.9759759927165201,0.4166666666666667,0.8355461348440089,1.0,30/91,21.61%,KIF16B;PLEKHA5;KRIT1;ADAP2;WDR45B;CLVS1;STXBP6;SNX14;SNX3;KCNH1;TTPAL;SNX21;LAPTM4B;SYT7;SYTL2;PFN1;GSN;VILL;SDCBP;LDLRAP1;HIP1;RPH3A;FCHO2;COMMD1;EXOC1;RAB35;KCNQ1;TIRAP;AVIL;OSBPL2
prerank,cardiolipin binding (GO:1901612),0.5054944897886914,0.9754634550497902,0.49698795180722893,1.0,1.0,2/10,14.51%,STOML2;GSDMD
prerank,phospholipase activity (GO:0004620),-0.2520294908357625,-0.9754528522620647,0.5283018867924528,0.830095047071536,1.0,11/67,9.38%,PLA2G4A;PLAAT3;ABHD6;ABHD12;ABHD16A;PNPLA6;LYPLA1;PLCB3;PNPLA8;GPLD1;PLD3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29964880458006593,-0.9749079120428529,0.4607329842931937,0.8252102858192143,1.0,4/24,4.87%,PLA2G4A;PLEKHA5;CERT1;SNX3
prerank,alpha-tubulin binding (GO:0043014),0.44437984161375976,0.9747408165061393,0.5030902348578492,1.0,1.0,9/31,20.64%,RACGAP1;SETD2;TRAPPC14;INO80;TAOK1;EML4;TRPV4;DIP2B;SNCA
prerank,metallocarboxypeptidase activity (GO:0004181),0.4524229706855467,0.9718993219455256,0.50187265917603,1.0,1.0,3/26,6.14%,VASH2;AGBL2;CPXM1
prerank,pentosyltransferase activity (GO:0016763),-0.26512436170499604,-0.9707725230224714,0.506578947368421,0.8283282387897751,1.0,9/36,13.03%,UPP2;PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;QTRT2;PARP16
prerank,GDP binding (GO:0019003),-0.23777253664472353,-0.9686320388268765,0.4918032786885246,0.8273120404963523,1.0,17/63,15.27%,RAB28;RAP1A;GNAI1;RAB27B;RAB5B;RERG;RALB;MRAS;RASL12;DYNC1LI1;RAB5A;RAB2A;RIT1;RAP2C;RAB12;RRAGC;ARL8B
prerank,calcium ion binding (GO:0005509),0.40484227668870193,0.9648834526902228,0.608,1.0,1.0,40/323,12.90%,EFCAB11;MELK;PON1;CDH15;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;ITPR1;PAM;TPM4;PRNP;CDH4;ANXA3;ANXA5;NDUFAB1;CABCOCO1;ENPP2;HPGDS;PPP3CA;ENPP3;FKBP9;ATP2A2;SLC8A1;TKT;TRPM2;CALM2;ANXA1;ENPP1;CALB1;MICU1;ITPR3;TRPM4;MEX3B;MAN1C1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24242069012840337,-0.9648300335534803,0.5353535353535354,0.8296858278753652,1.0,6/49,3.34%,PLA2G4A;CPNE8;PCLO;MCTP1;ANXA6;SYT1
prerank,cAMP binding (GO:0030552),-0.38627192533422305,-0.9638558231604745,0.4968944099378882,0.825570690424179,1.0,5/11,18.60%,HCN1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,NF-kappaB binding (GO:0051059),0.4478981067637273,0.963304397506239,0.4973958333333333,1.0,1.0,5/24,12.61%,SETD6;GSK3B;FAF1;HDAC1;HDAC2
prerank,glucuronosyltransferase activity (GO:0015020),0.4567718350081862,0.9632282883485044,0.5019206145966709,1.0,1.0,2/19,6.42%,LARGE1;CHSY1
prerank,cGMP binding (GO:0030553),-0.379422503647211,-0.9629396820243079,0.50625,0.8214491562554602,1.0,9/11,58.23%,PDE10A;PDE2A;PDE11A;CNGB1;CNGB3;RAPGEF2;CNGA2;CNGA4;CNGA3
prerank,hyaluronic acid binding (GO:0005540),-0.3904162319369533,-0.9627274508800289,0.49714285714285716,0.8157527475784735,1.0,7/10,36.55%,CEMIP;LAYN;IMPG2;C1QBP;HYAL2;LYVE1;CHODL
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24350830356809638,-0.9602933584526647,0.5238095238095238,0.8156420374419553,1.0,16/49,18.80%,PLCXD3;DUSP11;FRA10AC1;DUSP3;PRUNE1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;ATP1A2;GDPD1;PPP5C;EPHX2;PPP1CB;ACP6
prerank,transferrin receptor binding (GO:1990459),0.5065281099497532,0.9582698872483485,0.5107361963190185,1.0,1.0,3/10,9.77%,RGMA;SNX1;IKBKG
prerank,aspartic-type peptidase activity (GO:0070001),0.505202280997463,0.9571820121092686,0.5341426403641881,1.0,1.0,1/10,2.13%,CTSE
prerank,ribonuclease P RNA binding (GO:0033204),0.503553454638468,0.9563008281112825,0.512781954887218,1.0,1.0,4/10,19.60%,RPP40;RPP30;POP1;RPP21
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3886680673648105,-0.9562721371270523,0.5178571428571429,0.8191309524851079,1.0,3/10,5.78%,SLC8A3;SLC24A2;SLC3A2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40648916558794634,0.9552043593510774,0.524468085106383,1.0,1.0,18/71,17.65%,CDKN3;EYA4;PTPN2;ACP1;CDC25B;CDC25C;CDC25A;EYA2;PTPN21;PTPRS;PTPRA;PTPN13;PTPRU;MTMR3;PTEN;PTPRK;PTPRE;CDC14A
prerank,Toll-like receptor binding (GO:0035325),-0.3721444385302525,-0.9552035874927842,0.49854227405247814,0.815582272716453,1.0,9/11,48.25%,UNC93B1;TIRAP;TOLLIP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,ligand-gated cation channel activity (GO:0099094),-0.22564894480846287,-0.9548423305441042,0.6274509803921569,0.8105410661294739,1.0,20/75,23.69%,GRIK1;GRIN3A;GRIN2A;KCNJ3;GRIN2B;GRIK4;KCNJ6;KCNN2;CHRNA7;GRIA1;KCNJ10;GRIN1;MCOLN1;GRIA2;KCNK1;KCNJ12;GRIK2;P2RX4;KCNN3;PTK2B
prerank,manganese ion binding (GO:0030145),0.4223144995056592,0.9548401449114681,0.5318681318681319,1.0,1.0,9/48,12.42%,LARGE1;B4GALT1;PRIMPOL;TDP2;GALNT1;B4GALT7;PIM1;MPPED2;GYG1
prerank,pyrophosphatase activity (GO:0016462),0.41163100398875446,0.9546554804102267,0.53,1.0,1.0,13/50,13.58%,DHX9;LHPP;NUDT5;ENPP3;ITPA;PPA1;TRPM2;ENPP1;PLPP1;PLPP5;RNGTT;DXO;NUDT4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.44059044632676775,0.9536810344013902,0.5099882491186839,1.0,1.0,6/29,16.55%,SLC25A21;SLC38A7;SLC19A1;SLC25A30;SLC1A5;SLC25A22
prerank,MAP kinase kinase kinase activity (GO:0004709),0.49717081393297474,0.9534412321952014,0.5037481259370314,1.0,1.0,3/11,9.14%,MAP3K1;MAP3K20;MAP3K4
prerank,snRNA binding (GO:0017069),0.4158398193081161,0.9501422172059716,0.5040091638029782,1.0,1.0,12/42,16.58%,COIL;LSM11;DDX39B;TUT1;LSM2;HNRNPU;SNRNP35;SF3B3;DDX21;LSM7;LSM4;PRPF4
prerank,adenyl nucleotide binding (GO:0030554),-0.3785328982083847,-0.9489902894110733,0.5191082802547771,0.812374557532065,1.0,7/11,33.41%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3785328982083847,-0.9489902894110733,0.5191082802547771,0.812374557532065,1.0,7/11,33.41%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,SUMO transferase activity (GO:0019789),0.4685039587848559,0.9478703972574227,0.5,1.0,1.0,7/16,24.15%,TRIM28;NSMCE2;RANBP2;EGR2;HDAC4;PIAS1;UBE2I
prerank,endopeptidase activity (GO:0004175),0.40017939671391617,0.9476071518027871,0.625,1.0,1.0,39/257,14.18%,KEL;ESPL1;CTSE;MMP24;MMP28;MMP25;USP1;SENP1;TRABD2B;CASP7;MMP14;USP18;NLN;USP37;TASP1;ADAMTS10;PLAU;ADAMTS5;ADAMTS14;ADAMTS9;HTRA2;PSMB1;ADAMTSL2;USP16;ADAMTS2;ADAMTS16;TPP2;PSMB9;USP28;ADAM17;CASP8;CTSH;ADAMTSL3;USP9X;USP47;ADAM9;ADAM19;HTRA3;ADAMTS1
prerank,phosphotyrosine residue binding (GO:0001784),-0.26215341165733064,-0.9473199052100523,0.5378787878787878,0.8107380628447316,1.0,11/37,14.53%,PIK3R3;PIK3R1;SHE;BCAR3;IRS1;PFN1;ABL1;GRB2;PTPN11;LDLRAP1;SHC1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3943690182534936,0.9470174547159824,0.6136136136136137,1.0,1.0,48/254,15.81%,NR2E3;E2F2;MYBL1;E2F3;TFDP1;TFCP2L1;RFXAP;MDM4;NFIA;ZFP62;KLF5;SRF;ELF4;NFIB;HOXC4;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;ELK1;FOXO3;PLAGL2;IRF1;HOXB3;PLAGL1;MEOX2;NR4A2;NR3C1;ZNF585B;ZNF585A;RBPJ;NR4A1;SMAD4;ATF5;ELK4;YY1;RLF;FOXK2;SMAD3;E2F4;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;TP53
prerank,voltage-gated potassium channel activity (GO:0005249),-0.21952189106516118,-0.945818851832002,0.5555555555555556,0.8087255120561853,1.0,14/80,13.29%,KCNC2;HCN1;KCNB1;KCNJ3;KCNQ3;KCNH1;KCNJ6;KCNN2;KCNS3;KCNH7;KCNJ10;KCNA6;KCNA2;KCNT1
prerank,mRNA binding (GO:0003729),0.39279667235800647,0.9407414864134945,0.648,1.0,1.0,69/249,17.40%,TYMS;RBM15;SYNCRIP;PABPC4;MYEF2;LARP4B;AGO2;SRSF4;TRA2B;RBFOX2;CSTF3;KHDRBS1;DHX9;SRBD1;SERBP1;UPF3B;MYH10;EIF4ENIF1;SLBP;G3BP1;RBM25;SAMD4A;TPR;FMR1;YBX3;RBMS2;RC3H2;CELF2;LARP1;TUT1;RNF40;PPP1R8;CPEB2;PUM2;PCF11;SCAF8;HNRNPU;YTHDF2;RBPMS2;MRPL13;HNRNPL;SNRNP35;RBMS3;FUBP1;DXO;PTBP2;RBM4;DHFR;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;AQR;LUC7L3;SECISBP2;HNRNPA2B1;FXR1;GNL3;ACO1;UNK;TP53;METTL3;KHNYN;DENR;NUP98;ANGEL2;HNRNPLL;EDC3
prerank,RNA binding (GO:0003723),0.3939131420327051,0.9402043230198797,0.784,1.0,1.0,312/1321,18.23%,TOP2A;BRCA1;MKI67;NUSAP1;RAD51AP1;BARD1;KPNA2;ZGRF1;DDX11;HMGB2;RBM15;PNLDC1;ZC3H7A;ILF3;SYNCRIP;SMC1A;NAP1L1;MEX3A;LBR;FLYWCH2;MACF1;SETX;ADK;DEK;MOV10;PABPC4;MYEF2;TRIP6;DGCR8;ROCK2;SREK1;LARP4B;HDGF;AGO2;ANXA2;ZC3HAV1;SRSF4;HNRNPD;TRA2B;CNOT1;BICC1;ALG13;RBFOX2;CSTF3;PATL1;ACTN4;FIP1L1;DNTTIP2;KHDRBS1;PNISR;DNA2;UBAP2;DHX9;PRKDC;DIAPH1;SRBD1;PEG10;HNRNPA1;DDX50;SRF;TNPO1;EIF4E;SRSF10;SARS2;SERBP1;UPF3B;FAM120A;PRPF38B;THRAP3;MAPT;CCAR1;YLPM1;NUDT5;MYH10;LSM3;MBNL3;EIF4ENIF1;RAVER2;EIF4H;SLBP;CTNNA1;HMGN2;G3BP1;EXD1;PSIP1;RBM25;SAMD4A;FNDC3B;CAPRIN1;TPR;NMD3;ERI1;UBE2N;DDX39B;PSPC1;MAP3K20;PRPF40A;FMR1;RRS1;HNRNPH1;TXN;NOSIP;SRSF7;NUCKS1;YBX3;POLR2A;RBMS2;FUS;MEX3C;MATR3;DHX8;RC3H2;DNAJC21;PPIG;RPP40;MRM1;SAP18;CELF2;DARS2;LARP1;TRIM28;TUT1;TUT7;HNRNPUL1;DARS1;PELP1;NQO1;HMGB3;BCLAF1;PPP1R8;WDR33;PRPF3;NOL6;UTP3;MRM3;CPEB2;RBM42;NONO;SF3A2;PUM2;LONP1;MAP4;SRPRA;PRRC2B;HMGB1;MARK2;PCF11;HOXB6;RANGAP1;MRTO4;NOL11;DDX18;LSM2;SCAF8;SRSF3;SFPQ;HNRNPU;FASTKD5;YTHDF2;RBPMS2;TAF15;RARS2;SAMSN1;MRPL13;RBM15B;HNRNPL;SRPK1;SRRM1;CRKL;CPSF4;DHX37;CHD2;RPP30;EZR;GANAB;POP1;ESF1;SNRNP35;FAM32A;HTATSF1;ERH;SUGP2;EXOSC7;HNRNPUL2;COA6;EIF3C;SUMO2;RBMS3;DAP3;HNRNPH2;TSR1;FUBP1;MRPL1;TES;RPS17;SSRP1;HDAC2;NOM1;PPP1CC;ILF2;MEX3B;SIDT1;DUT;TCF20;PPAN;MEX3D;DXO;POLR1G;CAST;PTBP2;TUT4;RBM4;PPRC1;DHFR;DDX56;DDX21;LARP4;NUDT4;LSM7;SRP72;DRG2;DAZAP1;EIF1AX;SMG6;STRBP;YY1;RC3H1;ERI3;WBP4;EIF4A2;HLTF;TRMT2A;RBMS1;PRRC2A;NOL12;PABPC1;SNTB2;MAK16;EPRS1;EWSR1;AQR;LUC7L3;ZC3H14;TFB1M;SECISBP2;KIN;RBM19;HNRNPA2B1;ZC3H7B;FXR1;CKAP4;ADD1;GNL3;ACO1;LSM4;IPO5;HELB;PPIL4;UNK;DDX1;ZCCHC8;NUP42;CNOT4;RBM27;ZC3H18;RCC2;CISD2;LARP1B;PNPT1;TEP1;PURA;RALY;MSN;RPL22L1;AKAP1;METTL3;KHNYN;DENR;STXBP1;DHX38;SRP9;NUP98;MRPS24;UNC50;RBM10;PYM1;HNRNPLL;FCF1;PHF6;BZW1;MRPL45;TPD52L2;EDC3;ZC3H8;ASCC3;EIF3H;ZNF346;USO1;SRPK2;LUC7L2;ABT1;CWC22;MRPL42;PKN2;MRPL37;MRPL2;DDX10;MRPL20;RPL34;BUD13;GPATCH4;DDX59
prerank,cysteine-type peptidase activity (GO:0008234),0.39916200301524657,0.9392172137244578,0.5472689075630253,1.0,1.0,20/73,19.01%,ESPL1;USP1;CASP7;USP18;USP37;USP21;USP16;USP28;CASP8;CTSH;USP9X;USP47;OTUD7B;SFRP1;GGH;USP48;USP14;ATG4C;USP46;USP20
prerank,protein kinase inhibitor activity (GO:0004860),0.4143679587982538,0.9347484771388127,0.5497142857142857,1.0,1.0,12/42,20.64%,CIT;CEP43;PARVA;NCK1;SPRED1;CDKN1B;QARS1;RPTOR;SPRED2;SH3BP5;TRIB1;SNCA
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4691762430780768,0.9343022178010864,0.5302114803625377,1.0,1.0,5/12,19.33%,SLC19A1;SLC25A25;SLC25A42;SLC25A17;SLC25A5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.4680181159367577,0.933324868686943,0.5305832147937412,1.0,1.0,5/13,21.17%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,tumor necrosis factor receptor binding (GO:0005164),0.46644239686133765,0.9294863951856204,0.5291607396870555,1.0,1.0,5/12,24.18%,TRIM37;TRAF6;TRAF2;TRAF4;BABAM2
prerank,growth factor activity (GO:0008083),-0.21486088692858263,-0.9292000025561561,0.7073170731707317,0.8412137014626829,1.0,18/74,24.35%,NRG3;VEGFC;JAG1;FGF2;IGF2;TGFA;GRN;FGF1;VEGFA;JAG2;VEGFB;INHBA;VEGFD;CSPG5;HBEGF;BDNF;FGF10;FGF7
prerank,peptide hormone receptor binding (GO:0051428),-0.37084659085637856,-0.9291943253044704,0.5436241610738255,0.8353003047914659,1.0,4/11,34.41%,PSMC5;PTHLH;ADCYAP1;GNRH1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.32079248194351795,-0.9281200368478033,0.5168067226890757,0.8319956159185499,1.0,5/17,29.16%,SLC2A1;SLC2A3;SLC2A10;SLC5A11;SLC5A3
prerank,cholesterol transfer activity (GO:0120020),0.4576019945128956,0.9278709780345022,0.5430916552667578,1.0,1.0,1/16,1.29%,GRAMD1C
prerank,thioesterase binding (GO:0031996),0.4817922362808727,0.9272005864961007,0.5519287833827893,1.0,1.0,5/11,21.76%,HAUS7;RAC1;TRAF6;TRAF2;TRAF4
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2768639648571316,-0.9251357441110162,0.5497630331753555,0.8328721131066587,1.0,9/25,20.19%,SNX4;ERBB4;TGFA;GRB2;SNX2;HIP1;SHC1;LINGO1;HBEGF
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.4710560922826392,0.9251252321228522,0.5388059701492537,1.0,1.0,2/10,9.82%,NOX4;CYBB
prerank,voltage-gated anion channel activity (GO:0008308),-0.32972884387094553,-0.9250211915088181,0.5578231292517006,0.827347056169005,1.0,4/15,9.49%,ANO6;ANO1;GPR89B;GPR89A
prerank,filamin binding (GO:0031005),0.47580335931272455,0.9239353591020839,0.5395894428152492,1.0,1.0,4/11,12.85%,RFLNA;DPYSL4;DPYSL3;SYNPO2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.29482184717007714,-0.9236470822735148,0.5528846153846154,0.8244856543775043,1.0,6/20,15.02%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;SLC30A4;SLC39A1
prerank,BMP receptor binding (GO:0070700),0.4680313945050555,0.9218536424886055,0.5455861070911722,1.0,1.0,5/12,21.17%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.36578430222846414,-0.9217196308306166,0.5439560439560439,0.8232773719404919,1.0,2/10,15.78%,SLC6A1;SLC6A11
prerank,monocarboxylic acid binding (GO:0033293),0.43701856064511535,0.9211611789489798,0.5168831168831168,1.0,1.0,1/18,3.24%,CYP26B1
prerank,pyridoxal phosphate binding (GO:0030170),0.43486975684597906,0.9207480038162412,0.544,1.0,1.0,6/20,19.91%,PDXK;PYGB;AGXT;ABAT;ACCS;PYGL
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.40980456269288895,0.9202207021100213,0.5501165501165501,1.0,1.0,12/37,16.25%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;TARS2;PARS2;RARS2;QARS1;EPRS1;LARS1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.47578637271779944,0.920062084595019,0.5582137161084529,1.0,1.0,4/10,22.19%,PML;ANKRD13D;DNAJB2;DAXX
prerank,myosin II binding (GO:0045159),0.4845267500552565,0.9183693808155353,0.5243161094224924,1.0,1.0,3/10,9.28%,TRIOBP;STXBP5;LLGL2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4635712632914641,0.9162257452067762,0.5707692307692308,1.0,1.0,4/11,17.41%,SLC19A1;SLC25A25;SLC25A42;SLC25A17
prerank,tRNA methyltransferase activity (GO:0008175),-0.3276418553221743,-0.9157646632852753,0.5413533834586466,0.8308881508686584,1.0,7/16,35.54%,TRMT9B;THUMPD3;LCMT2;TRMT44;TYW3;TRMT12;BCDIN3D
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4643666310815089,0.9146396690044597,0.5532544378698225,1.0,1.0,4/12,10.48%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,zinc ion binding (GO:0008270),0.3825818826214068,0.9123967357883485,0.713,1.0,1.0,51/293,15.81%,UHRF1;TK1;ACMSD;GLI2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;ADA;PRIMPOL;LVRN;MDM4;MBD1;PAM;MYCBP2;BLM;SORD;PTGR2;PDXK;ENPP2;SMPDL3A;ENPP3;PHF2;TRIM28;KDM2B;ZFYVE1;USP16;CDA;DUSP12;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;ZDHHC15;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1;TP53
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4003168457383773,0.9120085097230897,0.614207650273224,1.0,1.0,11/55,10.74%,ATP2B4;ANXA9;ANXA2;ITPR1;PKD2L2;CUL5;MCU;ATP2A2;SLC24A3;TRPM2;ATP2B1
prerank,kinase activity (GO:0016301),0.38523643795244855,0.9114714675276173,0.6189989785495403,1.0,1.0,29/109,17.96%,MASTL;MAP4K4;GSK3B;PMVK;PDXK;IPMK;EPHA4;PAPSS2;LRRK2;FN3K;PPIP5K1;PIK3CB;IP6K2;DGKE;SEPHS1;PANK4;AGK;PKMYT1;PRKD1;PANK2;MVK;TAOK1;TRRAP;STK39;RFK;GK5;PI4KB;GK;PKN2
prerank,store-operated calcium channel activity (GO:0015279),-0.375524968487509,-0.9096493342289439,0.6061452513966481,0.8387923662665423,1.0,3/10,10.28%,TRPC5;TRPC3;TRPC1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.45437052330460026,0.9087128893322266,0.5552447552447553,1.0,1.0,1/13,2.38%,GPSM2
prerank,outward rectifier potassium channel activity (GO:0015271),0.46155489975717695,0.9072730354651224,0.56752655538695,1.0,1.0,3/11,16.34%,KCNK2;PKD2;KCNT2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3542538600938495,-0.9069524840270808,0.5623003194888179,0.8392358379298412,1.0,6/12,18.25%,PIK3R3;PIK3C2B;ATM;PIK3R6;PIK3CD;PIK3CA
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38985416241308557,0.9064155608064444,0.614900314795383,1.0,1.0,18/78,19.01%,ESPL1;USP1;CASP7;USP18;USP37;CAPN15;USP16;USP28;CASP8;CTSH;USP9X;USP47;CAPN5;SFRP1;USP48;USP14;USP46;USP20
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.25502918925656504,-0.9063508339719109,0.581081081081081,0.8352694316510109,1.0,21/35,37.13%,TRMT9B;DTWD2;PUS10;AARS1;QTRT2;PTRH2;QTRT1;NT5C3A;LCMT2;DTWD1;ALKBH1;DUS3L;ELAC2;QRSL1;MRPL58;GATC;TYW3;TRMT12;BCDIN3D;TRPT1;DUS2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4137168152643865,0.9040689704949029,0.5698795180722892,1.0,1.0,1/30,0.69%,BIRC5
prerank,protein phosphatase activator activity (GO:0072542),0.45682426265477855,0.9018358897093263,0.5702005730659025,1.0,1.0,6/13,20.12%,PPP2R5C;CALM2;PTPA;PPP2R5B;IGFBP3;PHACTR4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4513398750588375,0.9011562250558827,0.5669398907103825,1.0,1.0,6/15,15.82%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1;ABHD4
prerank,actin monomer binding (GO:0003785),-0.292733206823683,-0.9011521219333928,0.6055045871559633,0.8413282956673074,1.0,6/22,16.18%,TMSB4X;NOS3;PFN1;ABL1;TMSB10;MTSS1
prerank,ubiquitin protein ligase binding (GO:0031625),0.372550009892915,0.9008240629215796,0.717,1.0,1.0,37/254,11.39%,BRCA1;UBE2T;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;HERC2;UBOX5;ARRDC1;BAG5
prerank,diacylglycerol kinase activity (GO:0004143),-0.35560949201283165,-0.9004458227007567,0.5974842767295597,0.8374395746918731,1.0,6/11,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,nuclear receptor binding (GO:0016922),0.37369980974885775,0.899888773943778,0.6403688524590164,1.0,1.0,34/111,20.22%,TRIP6;CNOT1;MED14;ACTN4;ASXL1;THRAP3;LCOR;TCF7L2;MED30;ARID1A;MED24;SMARCA4;ZNHIT3;NR4A2;MMS19;NCOA2;GRIP1;PRKCB;TRIP12;NR4A1;NCOA7;PPID;MED1;SMAD3;JMJD1C;DCAF1;BRD8;TAF10;FOXP1;ARID5A;MED16;GTF2B;MED25;RNF14
prerank,1-phosphatidylinositol binding (GO:0005545),0.4375217548459419,0.8991834525534609,0.564673157162726,1.0,1.0,8/15,22.49%,SESTD1;ZFYVE16;ZFYVE1;PICALM;ZFYVE9;SNAP91;EEA1;SNX9
prerank,cell adhesion mediator activity (GO:0098631),-0.2817991710577257,-0.8986649676416425,0.5951219512195122,0.8357113919253291,1.0,8/24,19.10%,BSG;CNTN6;ESAM;BCAM;CNTN2;NTNG1;NEXN;ROBO4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4592754556054627,0.8975576150266631,0.5574468085106383,1.0,1.0,5/13,14.67%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,sterol transfer activity (GO:0120015),0.43963520036192716,0.8971126412068096,0.5771812080536913,1.0,1.0,1/17,1.29%,GRAMD1C
prerank,RNA cap binding (GO:0000339),0.4405098341487309,0.8967993429456438,0.5848032564450475,1.0,1.0,3/16,8.16%,AGO2;EIF4E;LARP1
prerank,androgen receptor binding (GO:0050681),-0.2733248032758058,-0.8962772948348366,0.6318407960199005,0.8352341092130716,1.0,8/25,20.33%,EP300;PRPF6;PRMT2;KDM4C;DDX5;TGFB1I1;PARK7;SNW1
prerank,NAD binding (GO:0051287),0.41168370613935246,0.8940667461245634,0.5943877551020408,1.0,1.0,5/26,10.38%,ZC3HAV1;CTBP1;SORD;ALDH1A1;PARP9
prerank,TBP-class protein binding (GO:0017025),0.4217571017942572,0.8934542899228586,0.5617529880478087,1.0,1.0,10/21,21.64%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1;GTF2B;GTF2A2
prerank,GTPase binding (GO:0051020),0.3765131819014507,0.8930756236262395,0.6946946946946947,1.0,1.0,41/195,14.59%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;STOML2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8;EPRS1;DOCK7
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2968541153473288,-0.8923091838052054,0.5930735930735931,0.8381538490512804,1.0,9/21,19.39%,AKAP8L;RYR2;AKAP6;GSKIP;AKAP7;ARFGEF2;ARFGEF1;AKAP8;KCNQ1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.358768444033875,-0.8906414777675769,0.6109422492401215,0.8363001139760903,1.0,4/10,8.12%,SLCO1C1;SLCO2B1;SLCO2A1;SLC22A6
prerank,neuropeptide receptor binding (GO:0071855),0.44117819785721657,0.8902875129105005,0.5834482758620689,1.0,1.0,1/14,3.51%,AGRP
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.44055795474593085,0.8900752812454364,0.5816901408450704,1.0,1.0,3/14,9.82%,NOX4;KMO;CYBB
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23849481157040775,-0.8879981837631747,0.7464788732394366,0.8366125515573385,1.0,7/37,8.12%,SLCO1C1;SLC22A8;SLCO2B1;COX4I1;COX5A;SLCO2A1;SLC22A6
prerank,adenylyltransferase activity (GO:0070566),0.42534268727867397,0.8873605291028536,0.571611253196931,1.0,1.0,8/21,20.25%,TENT2;TENT4A;TUT1;PAPOLB;NMNAT1;COASY;GPHN;NMNAT2
prerank,ligand-gated calcium channel activity (GO:0099604),0.42712036583574736,0.884989960981381,0.5767741935483871,1.0,1.0,6/19,12.51%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3;TRPM4
prerank,endoribonuclease activity (GO:0004521),-0.24790823362800063,-0.8848473063563765,0.6942675159235668,0.8380427078462598,1.0,13/32,27.69%,AGO1;AGO3;NYNRIN;DICER1;RIDA;ENDOV;ZC3H12A;EXOG;NOB1;TSNAX;RNASEL;INTS11;ZC3H12B
prerank,steroid hydroxylase activity (GO:0008395),0.43526555088132934,0.8841071103475552,0.5889655172413794,1.0,1.0,1/16,2.74%,CYP39A1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38595604037255804,0.8824481462854584,0.6219512195121951,1.0,1.0,12/49,18.54%,RAD18;ZRANB3;RNF168;UIMC1;AGAP3;IKBKG;BRCC3;OTUD7B;RNF169;RAD23B;EPS15;ZBTB1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2774401664547459,-0.8820325270443131,0.6333333333333333,0.8390771436441067,1.0,10/24,30.85%,KCNJ3;KCNJ6;KCNN2;KCNJ10;KCNK1;KCNJ12;KCNN3;ABCC9;KCNJ8;KCNJ15
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2873974202530468,-0.881329729036143,0.6111111111111112,0.8352923717629477,1.0,5/21,25.13%,GLRB;CHRNA7;GRIK2;P2RX4;P2RX7
prerank,transition metal ion binding (GO:0046914),0.3696348766306014,0.8811796852772543,0.793,1.0,1.0,65/397,15.49%,UHRF1;TK1;ACMSD;GLI2;LOXL3;LOXL2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;LARGE1;B4GALT1;ADA;PRIMPOL;LVRN;MDM4;MBD1;PAM;MYCBP2;TDP2;GALNT1;BLM;PRNP;SORD;PTGR2;PDXK;ENPP2;AGMO;SMPDL3A;ENPP3;PHF2;B4GALT7;TRIM28;KDM2B;SOD3;TYR;ZFYVE1;USP16;CDA;DUSP12;PIM1;MPPED2;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;COA6;ZDHHC15;GYG1;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1
prerank,R-SMAD binding (GO:0070412),0.4286630562824166,0.8803853300136597,0.5729032258064516,1.0,1.0,7/18,19.37%,PMEPA1;SMAD6;SMURF1;SMAD4;SMAD3;SMAD2;PPM1A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3370457241347039,-0.8783490451101312,0.6439628482972136,0.8361071068502463,1.0,5/13,31.59%,SREBF2;ECH1;IDI1;MIF;EBP
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30869597983783753,-0.8782843605355668,0.6159695817490495,0.8310981544398034,1.0,6/15,18.25%,PIK3R3;PIK3C2B;ATM;PI4KA;PIK3CD;PIK3CA
prerank,palmitoyltransferase activity (GO:0016409),-0.26760971314556287,-0.8759260067019164,0.6354166666666666,0.830859507489088,1.0,11/28,23.28%,GLUL;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,alkali metal ion binding (GO:0031420),0.4365888297980737,0.8750937978208264,0.5927007299270073,1.0,1.0,3/13,10.89%,PDXK;ACAT1;DRG1
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.29222272070363126,-0.8745820001763471,0.6392156862745098,0.8286635467555428,1.0,10/19,29.62%,NRG3;GAS6;GRM5;DGKQ;AFAP1L2;EFNA5;EGF;ERBB3;PAK2;CD24
prerank,ephrin receptor activity (GO:0005003),-0.2935250109165385,-0.8720956759077464,0.6212765957446809,0.8236174603678731,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.2935250109165385,-0.8720956759077464,0.6212765957446809,0.8236174603678731,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4119950183761037,0.8713227355326089,0.6033376123234917,1.0,1.0,6/22,15.44%,ZRANB3;RNF168;UIMC1;IKBKG;OTUD7B;RNF169
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.44909849876097085,0.8712873929687553,0.6011816838995568,1.0,1.0,6/12,24.54%,FXN;XDH;CISD2;ISCA2;SDHB;CIAPIN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3976395439146098,0.8704470287321077,0.6037735849056604,1.0,1.0,4/27,7.46%,TENT2;POLR1A;POLR1B;POLR2A
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.24655464064900623,-0.8701548260109707,0.6648648648648648,0.8229882059679438,1.0,10/32,23.52%,SLC6A6;SFXN2;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC25A38;SFXN3;SLC36A1;SLC6A7
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3928907532960467,0.8685044161682293,0.6140142517814727,1.0,1.0,12/35,18.25%,APEX2;TDP2;ENPP2;SMPDL3A;ENPP3;MPPED2;ENPP1;SMPD1;PLCB4;SMPD3;GDE1;SMPD2
prerank,RNA polymerase II complex binding (GO:0000993),0.3895202579109801,0.867194046709114,0.600470035252644,1.0,1.0,8/32,12.83%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;BRD4
prerank,ATPase regulator activity (GO:0060590),-0.23543586123573162,-0.8660297965963619,0.6428571428571429,0.8261671913460437,1.0,8/38,10.63%,ATP1B1;DNAJC24;DNAJC19;SIL1;DNAJA1;HSPH1;ATP1B3;PFN1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.39115513574563854,0.8634889718928693,0.623391812865497,1.0,1.0,18/35,25.41%,AGO2;POU2F1;SMARCA4;NR3C1;GTF2A1;HDAC1;TAF4;RUVBL2;DR1;TP53;DRAP1;FOXP1;GTF2B;UBTF;H3-3A;SMARCB1;RELA;BAZ2A
prerank,nucleotide diphosphatase activity (GO:0004551),-0.31679940198056683,-0.8628940937551174,0.6156351791530945,0.8276284844589774,1.0,6/14,22.65%,FHIT;NUDT3;ENPP4;ENPP5;NUDT6;NUDT12
prerank,heme binding (GO:0020037),0.36850403213902727,0.8619078051518422,0.6598712446351931,1.0,1.0,12/65,18.38%,DGCR8;CYP26B1;PTGES2;NOX4;PGRMC2;CYBB;CYB5B;HCCS;SRC;CYB5A;THAP4;PTGIS
prerank,mRNA 5'-UTR binding (GO:0048027),0.39138325340794966,0.8589216677582857,0.6047381546134664,1.0,1.0,4/24,8.16%,SYNCRIP;MYH10;FMR1;LARP1
prerank,metalloaminopeptidase activity (GO:0070006),0.4217621192677108,0.8585096622966376,0.6104252400548696,1.0,1.0,4/16,15.04%,MMP14;LVRN;TRHDE;NPEPPS
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3418663236661489,-0.8576306934254114,0.65814696485623,0.8330765021547014,1.0,2/11,20.20%,DDAH2;PADI2
prerank,N-acyltransferase activity (GO:0016410),0.39077027838893147,0.8571023098416651,0.6221142162818954,1.0,1.0,3/32,3.19%,NAT14;CERS6;CERS5
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.32551295639876715,-0.8569231633252922,0.6209386281588448,0.8295335188525119,1.0,5/14,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,calcium channel inhibitor activity (GO:0019855),0.44093853876289857,0.8525617869861091,0.6200873362445415,1.0,1.0,3/11,10.92%,ITPR1;MCUB;CALM2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.42133107414039295,0.8514323821796984,0.6190476190476191,1.0,1.0,2/14,14.09%,CAPN15;CAPN5
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36412307331256727,0.8497825588256531,0.6698113207547169,1.0,1.0,6/70,6.42%,HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1
prerank,ribosomal small subunit binding (GO:0043024),0.40771927505022515,0.8495103658325601,0.6167979002624672,1.0,1.0,4/17,9.41%,EIF4H;LARP1;CPEB2;PIM1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.42501768276602,0.8495091556707681,0.6291208791208791,1.0,1.0,4/14,17.40%,MINDY4;USP9X;OTUD7B;MINDY3
prerank,GABA receptor binding (GO:0050811),0.42793851334588073,0.8493998570551748,0.60932944606414,1.0,1.0,1/11,3.22%,TRAK1
prerank,glycerophospholipid flippase activity (GO:0140333),0.43714815891212727,0.8491281332589545,0.6277056277056277,1.0,1.0,2/11,4.57%,ABCA4;ABCB4
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.2923735421834809,-0.8486413161667484,0.6842105263157895,0.8406822142549828,1.0,5/17,25.11%,ACOT11;PPT1;ACOT7;ACOT13;ACOT6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.31006460645811207,-0.8444567194059129,0.6587301587301587,0.8437115900674029,1.0,5/15,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,carboxypeptidase activity (GO:0004180),0.3765913440701907,0.8434370364480148,0.6286379511059371,1.0,1.0,4/35,9.15%,VASH2;AGBL2;CPXM1;SCPEP1
prerank,metalloexopeptidase activity (GO:0008235),0.36974325933398133,0.8422391008959745,0.6736493936052922,1.0,1.0,11/51,18.07%,VASH2;MMP14;LVRN;AGBL2;CPXM1;CPQ;TRHDE;NPEPPS;AGTPBP1;METAP1;DPEP1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3201704984085331,-0.838763389187089,0.6596491228070176,0.8497636384365248,1.0,2/12,14.38%,SLC2A1;SLC2A3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.34908758535960027,0.8376196453266953,0.7733199598796389,1.0,1.0,31/181,14.42%,RBL1;SETD6;RB1;MIER1;RBBP8;GSK3B;DDRGK1;ACTN4;DHX9;BHLHE41;FAF1;MKKS;TCF7L2;ARID1A;ELK1;SMARCA4;MIER3;MTA3;PARP9;TAL1;TEAD3;NCOA2;HDAC1;TAF4;RBPJ;HDAC2;NCOA7;HEY2;MED1;SMAD3;ARNT
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3761472355958256,0.8350374295950869,0.6374407582938388,1.0,1.0,8/33,12.66%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;SPTY2D1;RPRD1A
prerank,gap junction channel activity (GO:0005243),0.3901140696880939,0.8329783846699713,0.6297229219143576,1.0,1.0,3/22,12.35%,GJD3;GJC1;GJA1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4283468159663914,0.8258825356192945,0.6759124087591241,1.0,1.0,5/10,24.92%,SIRPA;CD47;DSG2;CXADR;CD200
prerank,wide pore channel activity (GO:0022829),0.38436842349961914,0.8230706090297953,0.6408010012515645,1.0,1.0,3/23,12.35%,GJD3;GJC1;GJA1
prerank,tRNA binding (GO:0000049),-0.21063928598979514,-0.822457891484855,0.7962962962962963,0.8751113948237041,1.0,16/43,30.20%,EEF1A1;TRMT9B;AARS1;NSUN2;SARS1;DALRD3;TRMT10B;KARS1;TRMT10A;IGHMBP2;RPUSD4;ALKBH1;YARS2;PTCD1;YRDC;XPOT
prerank,I-SMAD binding (GO:0070411),0.4132595443113796,0.8224262905710101,0.6591865357643759,1.0,1.0,6/13,17.82%,SMAD6;SMURF1;TGFBR1;SMAD4;SMAD3;SMAD2
prerank,translation elongation factor activity (GO:0003746),-0.2962005158848356,-0.8205658389725432,0.7009966777408638,0.8739243509316769,1.0,5/14,25.03%,EEF1A1;EEF2;EEF1B2;TSFM;EIF5A2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4063688947489711,0.8200251549400506,0.6428571428571429,1.0,1.0,5/14,18.32%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,transcription coactivator binding (GO:0001223),0.3914022036582363,0.8182088959353233,0.6428571428571429,1.0,1.0,5/20,14.33%,CIT;AHR;SMAD4;RORA;SMAD3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3639944411636491,0.8159870721841693,0.6720741599073001,1.0,1.0,8/38,12.29%,SPAG9;FRS2;LRRK2;NCK1;MMS19;GRIP1;MAPK8IP3;NCK2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4239509711353031,0.8155021806430879,0.6532738095238095,1.0,1.0,3/10,16.82%,B4GALT1;B4GALT7;B3GALT2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36210858826378023,0.8137890529282624,0.6693091732729332,1.0,1.0,11/42,17.28%,ANXA2;RAB10;DSCAML1;DSCAM;ANXA1;EMB;PDLIM5;BAIAP2L1;TMOD3;SIRPA;CD47
prerank,phosphatidylinositol binding (GO:0035091),0.3462234402618173,0.8135086486089913,0.7287784679089027,1.0,1.0,30/91,22.49%,ITPR1;NUMA1;SNX1;PARD3B;MAPT;SESTD1;ZFYVE16;ZFYVE1;PICALM;SNX27;PITPNB;PIGU;AIDA;APPL2;ITPR3;DENND1A;MITD1;EXOC8;C2CD2L;PASK;PLEKHF2;ZFYVE9;DPEP1;SNAP91;EEA1;MYO1E;GPAA1;APPL1;PHF12;SNX9
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3851216845817348,0.8110271351224242,0.6520584329349269,1.0,1.0,4/18,10.48%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,endopeptidase activator activity (GO:0061133),0.41190540432928063,0.8085563849908733,0.6641337386018237,1.0,1.0,3/10,20.43%,PSMD14;ADRM1;PSME3
prerank,DNA-binding transcription factor binding (GO:0140297),0.33789836611879726,0.8071844925272796,0.8172690763052208,1.0,1.0,41/189,19.40%,RBL1;CBX5;RB1;MIER1;RBBP8;GSK3B;DDRGK1;DHX9;FHL2;BHLHE41;SRF;EIF4E;CTBP1;MKKS;TCF7L2;ELK1;MIER3;YAP1;HMGB1;MTA3;CXXC5;TAL1;RUNX1T1;TEAD3;HDAC1;RBPJ;HDAC2;TWIST1;HEY2;TLE4;SMAD3;TLE3;TP53;PURA;RERE;SMAD2;EGR2;RBL2;ZFPM2;SKI;ZFPM1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.32227431401318896,-0.8048609074288481,0.7123745819397993,0.8972383021854775,1.0,4/12,28.16%,DUSP3;DUSP1;DUSP8;DUSP6
prerank,receptor ligand activity (GO:0048018),0.34114601249539084,0.8042421855074462,0.8505516549648947,1.0,1.0,16/245,11.40%,TNFSF13B;HMGB2;ARTN;ERFE;WNT2B;BMP6;IL18;INSL6;FAM3C;SFRP2;WNT6;HMGB1;AGT;EDA;CNTF;BMP2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3224361947128084,-0.8013507365191661,0.707395498392283,0.8984570497855072,1.0,4/11,29.16%,SLC2A10;SLC5A11;SLC2A9;SLC5A3
prerank,NADP binding (GO:0050661),0.3600666768544293,0.8000971709122867,0.6874251497005988,1.0,1.0,8/32,19.51%,GMDS;LBR;DPYD;TM7SF2;DHFR;DHCR7;CRYZL1;ME3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.32859355251762834,-0.7995431199206959,0.6942857142857143,0.8964883700308475,1.0,4/10,22.02%,ANO6;ANO1;CLCN2;CLCN4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3675803557186846,0.7982430570750693,0.6640826873385013,1.0,1.0,4/22,13.09%,ILF3;CPEB2;RBMS3;MEX3D
prerank,acid-thiol ligase activity (GO:0016878),0.3998279539933009,0.7973976579873834,0.6671408250355618,1.0,1.0,2/13,14.00%,ACSS1;AACS
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.38696961374081823,0.7932215390390046,0.6736292428198434,1.0,1.0,5/20,14.67%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,cyclic nucleotide binding (GO:0030551),-0.25679087764661956,-0.7915238425027856,0.7452830188679245,0.9051628133597297,1.0,6/21,18.60%,HCN1;KCNH1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.35195648635254057,0.7911938266877356,0.696113074204947,1.0,1.0,11/33,21.24%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;DRAP1;RPRD1B;GTF2B;SMYD2
prerank,calcium activated cation channel activity (GO:0005227),0.3830368270239751,0.7911513308232969,0.6908602150537635,1.0,1.0,5/17,14.77%,KCNN4;KCNMB2;KCNMB3;TRPM4;KCNMB4
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4132112088672152,0.7895842296893331,0.6798780487804879,1.0,1.0,2/10,12.73%,CASP7;CASP8
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.39614331968052574,0.7882174157673407,0.699859747545582,1.0,1.0,4/15,15.57%,SETD3;KMT2A;KMT2D;SETD4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.39369428674596485,0.7867112724594844,0.66189111747851,1.0,1.0,5/12,19.93%,PDE3B;PDE7B;PDE7A;PDE4B;PDE4A
prerank,neuropeptide hormone activity (GO:0005184),0.370285283844675,0.7836386047618471,0.6929032258064516,1.0,1.0,1/22,3.51%,AGRP
prerank,snoRNA binding (GO:0030515),0.34482799281169024,0.7832670762393313,0.696969696969697,1.0,1.0,6/30,13.58%,PRKDC;NUDT5;DHX37;TSR1;DDX21;NUDT4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.402447274441476,0.7828846047769796,0.7098214285714286,1.0,1.0,3/11,12.12%,ITPR1;TRPC7;ITPR3
prerank,potassium ion leak channel activity (GO:0022841),0.3848199274393391,0.7824843406356999,0.686141304347826,1.0,1.0,3/15,12.52%,KCNK2;KCNK12;KCNK6
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3041336457364868,-0.7784261160226389,0.780327868852459,0.922129229241869,1.0,2/12,5.78%,SLC6A6;SLC3A2
prerank,muscle alpha-actinin binding (GO:0051371),0.38700017322818003,0.7782982734623871,0.68688293370945,1.0,1.0,4/15,15.58%,PDLIM4;PDLIM5;SYNPO2;PKD2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39200022712655164,0.7751106899755476,0.7008928571428571,1.0,1.0,3/11,24.62%,SLC25A47;SLC25A29;SLC22A4
prerank,neurexin family protein binding (GO:0042043),0.40004018662137436,0.7745923436427004,0.686838124054463,1.0,1.0,4/10,19.50%,NLGN3;SYTL4;NLGN2;SYTL5
prerank,syntaxin-1 binding (GO:0017075),-0.242395026562659,-0.7741306226712124,0.8311111111111111,0.9240855389450536,1.0,8/22,17.59%,UNC13B;SYT1;SYNPR;SNPH;CPLX1;VAMP3;SNAP25;SYPL1
prerank,hexosyltransferase activity (GO:0016758),0.3279484064103258,0.7738805115449776,0.8028600612870276,1.0,1.0,12/101,12.42%,POMT1;HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1;B4GALT7;HAS1;POFUT1;TMTC4;GYG1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3968349963635422,0.7725783226564268,0.7088414634146342,1.0,1.0,1/10,2.68%,ECHDC3
prerank,general transcription initiation factor binding (GO:0140296),0.3540805628279894,0.7714343364388748,0.7095115681233933,1.0,1.0,8/25,16.10%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1
prerank,ribonuclease activity (GO:0004540),0.334428846652816,0.7698147267961825,0.754614549402823,1.0,1.0,12/56,16.46%,AGO2;RNASE6;RNASEH2A;RPP40;CNOT6;PPP1R8;RNASE1;EXOSC7;RNASE12;SMG6;CNOT7;KHNYN
prerank,phosphatase activity (GO:0016791),0.32721794782536956,0.7683966089058492,0.7751046025104602,1.0,1.0,10/73,14.01%,PON1;LHPP;OCRL;LPIN2;PHOSPHO2;DUSP12;PLPP1;PLPP5;PPP1CC;ARMT1
prerank,G protein-coupled receptor binding (GO:0001664),-0.16805507972111475,-0.7682837249601001,1.0,0.9279344440694839,1.0,24/132,17.54%,PRKN;GNAI1;GNA12;HOMER1;BICD1;ARHGEF12;GNAL;DNAJA1;ITGB4;GNA14;ACE;GPRASP2;PACRG;AGTR1;PSMC5;STUB1;PTCH1;TAFA5;SDCBP;S1PR1;DVL1;LRP6;USP33;PICK1
prerank,cation transmembrane transporter activity (GO:0008324),0.3373162166139286,0.7667755458776144,0.7450110864745011,1.0,1.0,10/48,18.41%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,potassium:proton antiporter activity (GO:0015386),0.3930729947842711,0.7655219183963705,0.7204968944099379,1.0,1.0,1/10,8.58%,SLC9A5
prerank,sulfuric ester hydrolase activity (GO:0008484),0.39068037313100357,0.7621557251135286,0.6926470588235294,1.0,1.0,5/12,19.27%,SULF2;SULF1;ARSB;ARSI;ARSG
prerank,endopeptidase inhibitor activity (GO:0004866),0.32393583625247885,0.7620009176792667,0.7745901639344263,1.0,1.0,7/82,9.77%,SERPINB8;SERPINA9;ANXA2;PRNP;SERPINE1;ROCK1;AGT
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3891086133209565,0.7606537681342895,0.717948717948718,1.0,1.0,2/11,9.28%,PIGN;PTDSS2
prerank,anion transmembrane transporter activity (GO:0008509),0.38569015775706633,0.7603655291537669,0.7280575539568346,1.0,1.0,3/12,10.73%,SLC19A1;SLC4A2;SLC39A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3316602045640052,0.7591318060703884,0.7602150537634409,1.0,1.0,17/54,22.41%,MIER1;UPB1;DARS1;NADSYN1;MIER3;HDAC8;HINT1;HDAC1;ASRGL1;HDAC2;NTAN1;NTAQ1;ASPA;HDAC4;NAAA;SIRT2;MIER2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.38970296504224655,0.7571117147182395,0.723935389133627,1.0,1.0,2/11,12.73%,CASP7;CASP8
prerank,myosin V binding (GO:0031489),-0.2777392626405196,-0.7562436224647385,0.8007662835249042,0.9408590018478925,1.0,8/15,28.43%,RAB6B;RAB27B;RAB11A;RAB39B;RAB3D;RAB6A;RAB3B;RAB14
prerank,Tat protein binding (GO:0030957),-0.31123104068174273,-0.7537918487435208,0.7661538461538462,0.9395628041572129,1.0,2/10,7.57%,ACTB;DNAJA1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3553693821603024,0.7530932957791325,0.7509933774834437,1.0,1.0,8/20,25.15%,SENP1;USP21;USP9X;USP47;EIF3H;COPS5;USP25;UFSP2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3171275540598879,0.7507478614401772,0.8263103802672148,1.0,1.0,17/100,14.52%,RACGAP1;IQGAP2;ARFIP1;GBF1;MAPT;SESTD1;ZFYVE16;ZFYVE1;OSBPL8;SNX27;MAPKAP1;CYTH3;CLVS2;DENND1A;BTK;GSDMD;ATG2A
prerank,transforming growth factor beta receptor binding (GO:0005160),0.36244245558924304,0.7503159250739673,0.7493472584856397,1.0,1.0,6/18,17.82%,TGFBR3L;TGFBR3;SMAD6;TGFBR1;SMAD3;SMAD2
prerank,aminopeptidase activity (GO:0004177),0.3499311693772423,0.7485278565858946,0.7392373923739237,1.0,1.0,6/26,17.99%,MMP14;LVRN;TRHDE;CTSH;NPEPPS;METAP1
prerank,mannose binding (GO:0005537),-0.2790070769112809,-0.7478410303069127,0.7854889589905363,0.9426852765577137,1.0,8/12,53.51%,CLN5;LMAN2L;LMAN2;LMAN1;ACR;COLEC11;LMAN1L;CLEC4D
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3770331351798634,0.7469107658961969,0.7637906647807637,1.0,1.0,4/14,18.05%,MTHFR;PYCR1;DHFR;BLVRB
prerank,hormone activity (GO:0005179),0.32729198999325787,0.7441841301671335,0.7768052516411379,1.0,1.0,4/54,9.77%,AGRP;ERFE;INSL6;AGT
prerank,potassium channel activity (GO:0005267),0.3094837129499151,0.7430302826302246,0.8048016701461378,1.0,1.0,16/89,17.06%,AQP1;CCDC51;KCNN4;KCNK2;KCNH8;KCNH4;GRIK3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2;KCNT2;KCNA1
prerank,GTP binding (GO:0005525),0.3066221917236896,0.7384261922806609,0.8950554994954592,1.0,1.0,35/172,18.21%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;KRAS;NRAS;ARL5A
prerank,sterol binding (GO:0032934),0.31633966847407885,0.7370566289689046,0.754614549402823,1.0,1.0,17/56,20.88%,GRAMD1C;TSPO2;SOAT1;OSBPL8;SCAP;ABCA1;SOAT2;SIDT1;RORA;VDAC2;STARD3;SYP;ERLIN1;INSIG2;GRAMD1B;TSPO;INSIG1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3213645617478911,0.7350643374663531,0.7907488986784141,1.0,1.0,9/51,13.34%,SLCO4A1;SLC20A2;SLC35D1;SLC16A10;SLC35D2;SLC16A2;MCU;SLC25A30;SLCO3A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3041553842743656,0.7342204687956353,0.8965863453815262,1.0,1.0,39/196,18.21%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;SLC19A1;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;MPPED2;MIEF1;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;GNAI3;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;KRAS;NRAS;ARL5A
prerank,ribosome binding (GO:0043022),0.3203689092432546,0.7337594886415835,0.7858744394618834,1.0,1.0,13/46,19.34%,SERBP1;ERI1;EFL1;FMR1;NCLN;CPEB2;EIF3C;SRP72;MAIP1;PYM1;MTIF3;ETF1;CCDC47
prerank,sodium channel regulator activity (GO:0017080),0.32869114069655964,0.7336247785803525,0.7604166666666666,1.0,1.0,3/37,4.42%,ATP2B4;RANGRF;NEDD4
prerank,phosphatidic acid binding (GO:0070300),0.347975825107448,0.7324380855234002,0.7689133425034388,1.0,1.0,7/19,22.22%,PACSIN2;SESTD1;MAPKAP1;GSDMD;SMPD3;GRAMD1B;RAPGEF6
prerank,death domain binding (GO:0070513),-0.2876428176546142,-0.7323288418792194,0.8017751479289941,0.9592080748071601,1.0,6/11,21.90%,CRADD;BCL2;IRGM;DAPL1;BCL2L1;RACK1
prerank,MAP kinase activity (GO:0004707),0.36324775206909554,0.7315538583238151,0.7465564738292011,1.0,1.0,2/14,4.01%,NLK;MAPK4
prerank,potassium channel regulator activity (GO:0015459),0.31232299141260655,0.729905963197539,0.7831858407079646,1.0,1.0,12/49,19.33%,WNK1;KCNMB2;KCNMB3;KCNIP3;AKAP9;ADRB2;ENSA;DLG1;KCNMB4;DPP6;WNK3;AMIGO1
prerank,translation initiation factor activity (GO:0003743),0.3260691955769854,0.7281009451005106,0.7763761467889908,1.0,1.0,13/36,22.91%,AGO2;EIF4E;EIF2B1;EIF3C;EIF4A2;MTIF3;EIF3H;EIF3I;EIF2D;COPS5;EIF5;EIF2B5;EIF3B
prerank,mitogen-activated protein kinase binding (GO:0051019),0.337566678964336,0.7268789162077194,0.7657766990291263,1.0,1.0,7/29,20.68%,PPM1D;TPR;MAPKAPK3;MAPK14;DUSP7;ATF7;MAPKAPK2
prerank,protease binding (GO:0002020),0.30568489261901033,0.7262444898750258,0.8317948717948718,1.0,1.0,19/99,16.96%,BRCA2;FADD;ANXA9;GSK3B;ANXA2;PRNP;LCOR;DERL2;SERPINE1;RIOK3;BDKRB2;ADRM1;INSL3;ITGB1;ITGAV;TP53;STIM1;PTEN;LDLR
prerank,galactosyltransferase activity (GO:0008378),0.3729289122754418,0.7259004955730695,0.7656012176560122,1.0,1.0,2/11,7.96%,B4GALT1;B4GALT7
prerank,frizzled binding (GO:0005109),0.3246039901303004,0.725612430083986,0.7708578143360753,1.0,1.0,6/34,19.03%,WNT2B;RNF43;WNT6;WNT9A;SFRP1;WNT4
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.22568003518395258,-0.7221450589772659,0.9043062200956937,0.9669116082286224,1.0,8/23,29.21%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3608908394379595,0.7219246717361516,0.7456647398843931,1.0,1.0,4/13,18.17%,SLC38A7;SLC15A4;SLC7A1;SLC25A29
prerank,CoA-ligase activity (GO:0016405),0.355306883088188,0.7215895511223618,0.758765778401122,1.0,1.0,2/14,14.00%,ACSS1;AACS
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.24696999523010754,-0.7211095234688467,0.8244274809160306,0.9632226095030716,1.0,9/17,29.50%,AK3;CMPK1;NME6;AK5;AK4;CMPK2;CLP1;AK1;NME2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1942917963890616,-0.7207373229197677,0.9421487603305785,0.9585910327820728,1.0,13/40,23.84%,PCMTD2;PCMTD1;HNMT;THUMPD3;N6AMT1;TPMT;NNMT;PRMT8;RRP8;METTL9;MEPCE;SUV39H1;COMT
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.36089711237893407,0.7180125779882522,0.7686567164179104,1.0,1.0,4/12,26.70%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,protein kinase C activity (GO:0004697),0.35925219050553975,0.7158329162837149,0.7485549132947977,1.0,1.0,7/14,20.98%,PRKCB;PRKCA;PRKCE;PRKD1;PRKCI;PRKCD;PRKD3
prerank,cholesterol binding (GO:0015485),0.31160038625817055,0.7151228454540153,0.776536312849162,1.0,1.0,11/47,16.59%,GRAMD1C;TSPO2;SOAT1;OSBPL8;ABCA1;SOAT2;SIDT1;VDAC2;STARD3;SYP;ERLIN1
prerank,double-stranded RNA binding (GO:0003725),0.3044035936624332,0.7112930799005265,0.8198103266596417,1.0,1.0,15/70,17.54%,ILF3;DGCR8;AGO2;DHX9;EIF4H;FMR1;RC3H2;HNRNPU;ILF2;SIDT1;STRBP;RC3H1;FXR1;MSN;ZNF346
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3629357848074441,0.7092844499289072,0.7731958762886598,1.0,1.0,1/11,3.44%,MAP4K2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.3287865865480697,0.7058336347226384,0.7717948717948718,1.0,1.0,2/21,12.03%,ANXA9;CHRNB1
prerank,mannosyltransferase activity (GO:0000030),0.3328055838271664,0.7044118625195144,0.762532981530343,1.0,1.0,4/21,15.81%,POMT1;TMTC4;ALG8;PIGM
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.32102125968149164,0.6999808641264276,0.7923566878980892,1.0,1.0,5/24,14.72%,PMVK;PPIP5K1;IP6K2;DTYMK;AK7
prerank,proton transmembrane transporter activity (GO:0015078),-0.18738337830573365,-0.6994052629525681,0.9596774193548387,0.9785990185484688,1.0,15/39,34.23%,COX4I1;COX5A;NDUFA4;UQCR10;UQCRQ;CLCN4;COX8A;UQCRC1;COX5B;CTNS;ATP6V1B2;UQCRFS1;ATP6V1F;SLC9A1;COX6B1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.303821182237082,0.6989514894901309,0.8163716814159292,1.0,1.0,11/53,18.41%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC25A22;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,chemoattractant activity (GO:0042056),0.321752605388206,0.6950141380214432,0.7894088669950738,1.0,1.0,1/26,1.44%,HMGB2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.20921485993057073,-0.6935305518517697,0.9090909090909091,0.9797463349030493,1.0,11/26,31.85%,PPP1R1A;SET;PPP1R11;PPP1R14A;PABIR1;MGAT5;PPP1R14B;BOD1;SAG;STYXL1;CABIN1
prerank,deubiquitinase activity (GO:0101005),0.29612346844444043,0.6913690570161558,0.8788819875776398,1.0,1.0,26/88,22.60%,MINDY4;USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;EIF3H;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,protein phosphatase regulator activity (GO:0019888),0.30054290036906034,0.6896578820349278,0.825136612021858,1.0,1.0,17/53,21.33%,PPP2R3A;PPP1R7;PPP2R5C;CALM2;PPP2R2D;ENSA;PPP1R15B;PTPA;PPP2R5B;PPP2R1B;ANKLE2;PPME1;PPP6R2;BOD1L1;PHACTR4;PPP4R1;EIF2AK2
prerank,sodium:proton antiporter activity (GO:0015385),0.3485363892692163,0.6884064323660773,0.8036529680365296,1.0,1.0,1/11,8.58%,SLC9A5
prerank,anion:anion antiporter activity (GO:0015301),0.3364170269839316,0.6883638397257892,0.8041504539559015,1.0,1.0,2/17,8.19%,SLC19A1;SLC4A2
prerank,serine-type endopeptidase activity (GO:0004252),-0.16144454873297825,-0.6882729156313275,1.0,0.980297529123877,1.0,11/80,21.37%,PCSK5;PIK3IP1;PCSK6;FURIN;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.26778393113669674,-0.6878860859715206,0.8765822784810127,0.9756036396844912,1.0,5/11,29.08%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;PPP1R14B
prerank,GTPase activity (GO:0003924),0.2849474723395754,0.6873483094454006,0.9367469879518072,1.0,1.0,32/192,15.74%,RAB33B;RHOA;GNG8;ABCA4;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;GNAQ;RHOQ;DNM2;TPPP;SRPRA;RAB1A;DRG1;RND2;RAC1;RRAS;TSR1;GNAI3;DRG2;GNG5;GFM2;RHOC;MFN1
prerank,phospholipase C activity (GO:0004629),-0.20995993468801688,-0.6848126345730391,0.9533678756476683,0.9735639963753541,1.0,8/25,29.21%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,clathrin adaptor activity (GO:0035615),0.337025143209719,0.6833364637660185,0.7923497267759563,1.0,1.0,2/15,5.97%,STON1;STON2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3587622398923613,0.6828203277327982,0.8054711246200608,1.0,1.0,3/10,18.07%,DPYSL4;DPYSL3;DPEP1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21666501447959868,-0.6824209106249286,0.9,0.9711691345549253,1.0,8/24,23.28%,GLUL;ZDHHC1;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC20;ZDHHC4;ZDHHC17
prerank,potassium ion antiporter activity (GO:0022821),0.3329357084292045,0.6794939142517488,0.8157524613220816,1.0,1.0,2/15,9.37%,SLC9A5;SLC24A3
prerank,alpha-actinin binding (GO:0051393),0.31894109790529546,0.6748308661007644,0.7982120051085568,1.0,1.0,5/24,15.58%,PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.312600334763947,0.6714897102222747,0.81625,1.0,1.0,3/25,9.79%,CYP26B1;MICAL3;KMO
prerank,NAD+ binding (GO:0070403),0.34049850788037295,0.6710271597911365,0.8139880952380952,1.0,1.0,2/12,10.38%,ZC3HAV1;PARP9
prerank,hydro-lyase activity (GO:0016836),0.29494957667914645,0.6690811758418506,0.8356164383561644,1.0,1.0,7/41,16.57%,GMDS;ECHDC3;PCBD2;APIP;CA2;ACO1;ECI1
prerank,ribosomal large subunit binding (GO:0043023),0.3425527931054445,0.6687937781792259,0.8136094674556213,1.0,1.0,2/11,9.13%,NMD3;CPEB2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3392554460418106,0.6686946721667177,0.8309037900874635,1.0,1.0,12/12,66.10%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,phospholipase binding (GO:0043274),0.33804593236283503,0.6685059496201956,0.8095238095238095,1.0,1.0,7/13,25.61%,ARHGAP6;PDPK1;BTK;SRC;FYN;BLNK;PAFAH1B1
prerank,lipoprotein particle binding (GO:0071813),0.3158394577211837,0.6638156974362542,0.8236842105263158,1.0,1.0,4/20,16.96%,COLEC12;MAPT;LPL;LDLR
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28202603195651627,0.6636316774074443,0.8735751295336788,1.0,1.0,14/85,17.51%,PON1;ENPP2;BCHE;TARS2;ACHE;DAGLB;APMAP;CA2;PON2;LPL;ABHD4;NOTUM;GDE1;PNPLA7
prerank,N-acetyltransferase activity (GO:0008080),0.31652780483406423,0.6636024076323996,0.8309305373525557,1.0,1.0,1/19,1.96%,NAT14
prerank,acetylcholine receptor activity (GO:0015464),0.30716235242149503,0.662527475515776,0.8325,1.0,1.0,2/22,12.03%,ANXA9;CHRNB1
prerank,sialyltransferase activity (GO:0008373),0.31090697334418677,0.6588086404718886,0.8295904887714664,1.0,1.0,6/20,15.44%,ST8SIA2;ST3GAL3;ST3GAL5;ST3GAL4;ST3GAL1;ST3GAL2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.27463498368781253,0.6569203130896926,0.9143145161290323,1.0,1.0,24/134,18.41%,SLC25A15;SLC25A21;SLCO4A1;SLC38A7;PDPN;SLC19A1;SLC25A2;SLC35D1;SLC25A25;SLC35D2;SLC39A8;GJA1;SLC38A9;SLCO3A1;SLC19A2;SLC15A4;SLC1A5;SLC25A42;SLC25A22;SLC36A4;SLC7A1;SLC25A17;SLC6A9;SLC38A2
prerank,sulfotransferase activity (GO:0008146),0.29998738987741114,0.6509886328658493,0.8347305389221557,1.0,1.0,4/33,10.90%,CHST15;CHST3;UST;HS2ST1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.27729364318339395,0.6489905987711251,0.8758029978586723,1.0,1.0,9/60,9.97%,FGFR4;FGFR2;KIT;MUSK;PDGFRA;CRIM1;EPHA4;FGFRL1;DDR2
prerank,ion channel inhibitor activity (GO:0008200),0.28585735656730404,0.648505285697815,0.8571428571428571,1.0,1.0,7/35,13.51%,ITPR1;NEDD4;WNK1;KCNMB2;MCUB;CALM2;ENSA
prerank,semaphorin receptor activity (GO:0017154),0.33452117394118486,0.6465831957155289,0.8397626112759644,1.0,1.0,6/11,23.43%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3;PLXNA1
prerank,Wnt-activated receptor activity (GO:0042813),-0.23048896249054696,-0.6447021557330008,0.8966789667896679,1.0,1.0,5/15,26.81%,FZD2;FZD4;FZD1;TSPAN12;FZD8
prerank,O-methyltransferase activity (GO:0008171),-0.2591440362377011,-0.6445001281424464,0.925,0.9952132957201594,1.0,4/10,23.84%,COQ3;CMTR1;MEPCE;COMT
prerank,ferrous iron binding (GO:0008198),0.3018273222053979,0.6407330621979921,0.8527131782945736,1.0,1.0,2/21,3.91%,FXN;FTO
prerank,metal ion:proton antiporter activity (GO:0051139),0.31698122257329914,0.6386732833083947,0.8682284040995608,1.0,1.0,4/13,26.70%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,ADP binding (GO:0043531),0.2995255439411749,0.6374706083902464,0.8522588522588522,1.0,1.0,6/25,15.28%,MYH10;LONP1;MYO9B;MIEF1;MSH6;PRKAG1
prerank,exoribonuclease activity (GO:0004532),0.3286445903173282,0.6373013989650421,0.8535127055306427,1.0,1.0,4/12,18.35%,CNOT6;EXOSC7;CNOT7;EXOSC10
prerank,phosphatidate phosphatase activity (GO:0008195),0.32436640169467984,0.6357458393298622,0.8175287356321839,1.0,1.0,3/13,12.30%,LPIN2;PLPP1;PLPP5
prerank,methyltransferase activity (GO:0008168),0.27451045661415546,0.6335736257321124,0.8822222222222222,1.0,1.0,10/46,17.45%,METTL27;AMT;EEF1AKMT2;MGMT;ASMT;METTL4;ARMT1;MRM2;METTL3;NSUN3
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.23114592541790147,-0.6311501798904436,0.9423728813559322,1.0,1.0,7/14,29.50%,CMPK1;NME6;AK5;AK4;CMPK2;AK1;NME2
prerank,omega peptidase activity (GO:0008242),0.2690766851626544,0.6288392517136188,0.9186405767250257,1.0,1.0,28/89,23.70%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;ASRGL1;USP9X;USP47;BRCC3;OTUD1;OTUD7B;GGH;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1;APEH;USP25
prerank,triglyceride lipase activity (GO:0004806),-0.2155462788750198,-0.6282328568843873,0.9595141700404858,0.9973264763172899,1.0,6/20,31.16%,ABHD5;PLA2G15;PNPLA2;PNPLA3;LIPE;DDHD2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.27469901002732844,0.6276900023680709,0.8905191873589164,1.0,1.0,13/47,21.71%,SLC38A7;PDPN;SLC38A4;SLC16A2;SLC38A9;SLC1A5;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11;SLC6A13
prerank,phosphatidylcholine transporter activity (GO:0008525),0.29767321252086193,0.6270146292650312,0.8435754189944135,1.0,1.0,3/17,11.77%,ABCB4;PITPNB;ABCA1
prerank,NADPH binding (GO:0070402),0.3088605963627858,0.6268899209829103,0.8457142857142858,1.0,1.0,1/13,2.57%,LBR
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3247709562371779,0.6266022768977736,0.8555900621118012,1.0,1.0,3/10,16.40%,SETDB2;ASH1L;SUV39H2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3090192979126156,0.6242456267186682,0.858806404657933,1.0,1.0,4/13,17.31%,GSK3B;EZR;PRKAR2B;PRKAR2A
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.22016057165406916,-0.62073816087689,0.9370629370629371,0.9979109696156737,1.0,2/16,12.60%,SLC44A1;SLC22A5
prerank,thiol-dependent deubiquitinase (GO:0004843),0.26628078816862083,0.6195778170321298,0.925,1.0,1.0,24/83,22.60%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3161937418395518,0.6164610378440292,0.8689547581903276,1.0,1.0,4/10,17.31%,PKIG;PRKAG1;PRKAR2B;PRKAR2A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.2882132685395993,0.6151549949767973,0.871536523929471,1.0,1.0,6/21,19.93%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A
prerank,serine-type peptidase activity (GO:0008236),-0.13792420197278177,-0.6128723515828398,1.0,0.9981472254879984,1.0,12/96,21.37%,PCSK5;PIK3IP1;PCSK6;FURIN;TPP1;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,ephrin receptor binding (GO:0046875),0.29424138324667976,0.6120266362292213,0.857516339869281,1.0,1.0,8/21,23.73%,EFNA1;EFNB1;ANKS1B;EFNB2;SRC;PTPN1;FYN;CRK
prerank,G protein-coupled receptor activity (GO:0004930),0.2549587603433627,0.6097371205243948,0.9849246231155779,1.0,1.0,24/239,16.35%,GPR171;LPAR3;ADGRV1;LPAR1;GALR1;NPFFR2;ADGRL1;GPR173;CXCR4;BDKRB2;NPR3;TAPT1;P2RY1;S1PR2;GLP2R;ADGRG2;ADRB2;GPR156;ELOVL4;LANCL1;GABBR2;CYSLTR2;ADGRD1;GPR135
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.30684448155504496,0.6067058806401684,0.8797564687975646,1.0,1.0,5/12,24.24%,PHF2;JMJD1C;KDM4B;HR;KDM1A
prerank,estrogen receptor binding (GO:0030331),0.27614082664035117,0.6056415696612837,0.8882211538461539,1.0,1.0,7/32,16.08%,CNOT1;LCOR;MMS19;PPID;MED1;DCAF1;TAF10
prerank,phosphatase inhibitor activity (GO:0019212),0.2826751003671433,0.5996231082632351,0.8896103896103896,1.0,1.0,5/20,19.58%,ANP32E;ENSA;PPME1;STYX;BOD1L1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.22518501402569957,-0.5996022841937767,0.9482071713147411,1.0,1.0,5/14,33.59%,SLC26A11;SLC25A11;SLC26A2;SLC26A6;SLC26A8
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.27366288519084325,0.59482822587212,0.8916083916083916,1.0,1.0,6/30,17.00%,SLC25A37;SLC39A11;SLC39A8;SLC39A6;SLC30A10;SLC25A28
prerank,cation channel activity (GO:0005261),0.255259648288198,0.5932930583109023,0.9439252336448598,1.0,1.0,20/94,20.21%,AQP1;ANXA9;ANXA2;TRPA1;PKD2L2;CUL5;CALHM2;MCU;SLC24A3;TRPM2;PIEZO1;TRPM4;PKD2;KCNA1;TRPV4;KCNQ4;TRPM6;TMEM63A;KCNK5;PIEZO2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.296008477473784,0.5870076071200108,0.8975109809663251,1.0,1.0,2/11,13.58%,NUDT5;NUDT4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.27455310192020377,0.5857559676117744,0.9041614123581336,1.0,1.0,7/24,20.68%,MYLK3;PHKA2;CAMK1D;MAPKAPK3;CAMKV;DAPK1;MAPKAPK2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2877233701727118,0.5837440142349756,0.8995983935742972,1.0,1.0,4/16,16.55%,SLC38A7;SLC25A30;SLC1A5;SLC25A22
prerank,Hsp90 protein binding (GO:0051879),0.2660277232185676,0.5836623551388177,0.8988372093023256,1.0,1.0,5/33,13.25%,MAPT;HDAC8;NR3C1;AHR;PPID
prerank,FMN binding (GO:0010181),-0.2328658317668264,-0.5834335259017254,0.93125,1.0,1.0,8/11,46.18%,NOS3;MTRR;NOS1;NDOR1;DUS2;PNPO;POR;NOS2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.2738069114087361,0.583071013044216,0.9081632653061225,1.0,1.0,7/23,22.13%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A;ADPRM
prerank,transforming growth factor beta binding (GO:0050431),0.2769568508709957,0.5820349347102818,0.8974683544303798,1.0,1.0,4/23,14.99%,TGFBR3L;TGFBR3;TGFBR1;ITGAV
prerank,protein phosphorylated amino acid binding (GO:0045309),0.261541594286921,0.5749617834884826,0.9297052154195011,1.0,1.0,11/42,20.48%,NEDD4;FBXW7;VAV2;SAMSN1;CRKL;NCK2;PIN1;SHB;YES1;PTPN5;SHF
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2665728403715876,0.5742708510345242,0.8952496954933008,1.0,1.0,3/27,9.71%,SLC9A5;SLC8A1;CNNM4
prerank,histone demethylase activity (GO:0032452),0.26128353780022046,0.5742483510784848,0.9154040404040404,1.0,1.0,9/27,25.22%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.29522923499961384,0.5720995742896006,0.9004893964110929,1.0,1.0,3/10,21.62%,KDM2B;KDM4B;KDM2A
prerank,adrenergic receptor binding (GO:0031690),0.277771856992949,0.5705193251882575,0.9071729957805907,1.0,1.0,1/16,4.42%,NEDD4
prerank,O-acyltransferase activity (GO:0008374),0.2635700193960644,0.5702989490503256,0.9172661870503597,1.0,1.0,3/30,12.02%,LPCAT1;SOAT1;SOAT2
prerank,solute:sodium symporter activity (GO:0015370),0.25892025374751165,0.5682537982420529,0.9074733096085409,1.0,1.0,1/27,4.09%,SLC20A2
prerank,glutathione transferase activity (GO:0004364),0.2655399391277384,0.5673317965340878,0.9098984771573604,1.0,1.0,6/23,22.10%,HPGDS;LANCL1;GSTT1;MGST3;GSTM5;GSTZ1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24347793443070798,0.5665458627333101,0.950836820083682,1.0,1.0,17/74,19.08%,ADK;PDXK;IPMK;PAPSS2;PIK3CB;DGKE;PANK4;AGK;PANK2;MVK;RFK;NOL9;GK5;PI4KB;GK;GALK2;COASY
prerank,transaminase activity (GO:0008483),0.28614066062759647,0.5628403489461102,0.9218523878437048,1.0,1.0,2/11,10.09%,AGXT;ABAT
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2400984348669311,0.5591959890202374,0.941304347826087,1.0,1.0,10/55,18.41%,SLC38A7;PDPN;SLC38A4;SLC19A1;SLC16A2;SLC38A9;SLC19A2;SLC36A4;SLC7A1;SLC38A2
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2244723244101592,-0.5587836353615657,0.9601139601139601,1.0,1.0,5/10,33.01%,NAA25;NAA80;NAA30;NAA16;NAA10
prerank,calcium channel activity (GO:0005262),0.23504555954384426,0.5567102266605833,0.9532224532224532,1.0,1.0,15/84,16.37%,ANXA9;ANXA2;CACNA2D3;PKD2L2;CUL5;MCU;SLC24A3;CACNA1C;TRPM2;TRPC7;TRPM4;ITGAV;PKD2;CACNB4;TPCN2
prerank,low-density lipoprotein particle binding (GO:0030169),0.26882832138308477,0.5516970872549455,0.9296551724137931,1.0,1.0,1/16,3.24%,COLEC12
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.27820346530103324,0.5490367668790119,0.9357142857142857,1.0,1.0,1/12,5.13%,B3GNT8
prerank,tropomyosin binding (GO:0005523),0.2690311634283776,0.5484711709358524,0.9071618037135278,1.0,1.0,5/16,22.27%,TMOD3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,RNA methyltransferase activity (GO:0008173),0.2668186748167462,0.5484256068675437,0.9098250336473755,1.0,1.0,8/19,27.80%,METTL4;METTL8;MRM2;METTL3;TGS1;TRMT5;TRDMT1;TRMT13
prerank,peptidase activator activity (GO:0016504),0.25261050520900824,0.545595789068736,0.9277566539923955,1.0,1.0,6/22,21.07%,CASP8AP2;PSMD14;ADRM1;PSME4;PSME3;TANK
prerank,cytokine activity (GO:0005125),0.22843366663077758,0.5438763659765534,0.9738430583501007,1.0,1.0,10/131,12.50%,CKLF;WNT2B;BMP6;IL18;FAM3C;WNT6;HMGB1;CNTF;BMP2;WNT9A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.22917268201683377,-0.5407292982909098,0.9617834394904459,1.0,1.0,3/10,16.94%,CACNA1B;CACNB2;CACNB1
prerank,SH2 domain binding (GO:0042169),0.24808761599547718,0.540671001232917,0.9463647199046484,1.0,1.0,6/31,17.59%,NLK;KHDRBS1;AFAP1;SRC;SH3PXD2B;TRPV4
prerank,N-methyltransferase activity (GO:0008170),0.25491958239079615,0.5374036253751799,0.9391534391534392,1.0,1.0,4/20,14.96%,SETD3;METTL15;METTL5;TFB1M
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.24329269941846737,0.5355307880669474,0.934040047114252,1.0,1.0,1/29,1.97%,HPSE
prerank,nucleoside-diphosphatase activity (GO:0017110),0.26870424784228064,0.5348359621093658,0.9375,1.0,1.0,2/12,16.43%,NUDT5;SLC25A42
prerank,phosphatidylglycerol binding (GO:1901611),0.264899357458921,0.5342613123470369,0.938953488372093,1.0,1.0,2/13,14.51%,STOML2;GSDMD
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2271190000328321,0.5326055897414601,0.9699792960662525,1.0,1.0,10/72,14.59%,ANXA9;ANXA2;SESTD1;PICALM;MAPKAP1;TWF1;SNX18;SVIL;GSDMD;CAPG
prerank,iron ion binding (GO:0005506),0.2287364937394818,0.5305322291158276,0.9581497797356828,1.0,1.0,4/48,7.90%,FXN;FTO;AGMO;PHF2
prerank,C-C chemokine receptor activity (GO:0016493),0.2523546770841549,0.5300462945036709,0.9406451612903226,1.0,1.0,1/21,6.30%,CXCR4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.1924994262823574,-0.529627711047125,0.9659090909090909,1.0,1.0,5/15,24.08%,COX4I1;COX5A;NDUFA4;COX8A;COX5B
prerank,chemokine activity (GO:0008009),0.23721214840004246,0.5293227083163214,0.9423769507803121,1.0,1.0,1/31,4.99%,CKLF
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.232247687646522,0.5288380080085338,0.9666295884315906,1.0,1.0,3/46,6.06%,LARGE1;B3GNT8;PIGA
prerank,endopeptidase regulator activity (GO:0061135),0.23082444550009312,0.5200056725315344,0.9657534246575342,1.0,1.0,10/40,24.03%,PSMD14;ADRM1;CAST;USP14;PROS1;PSME3;TFPI;RECK;PSMF1;ITIH2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2599639637935384,0.5198132082587203,0.9452662721893491,1.0,1.0,1/11,12.03%,CHRNB1
prerank,cytokine receptor binding (GO:0005126),0.2229000581037728,0.5189888005012144,0.9782383419689119,1.0,1.0,12/83,20.26%,FADD;TRIP6;IL18;TGFBR3;CNTF;ADAM17;SPRED1;SMAD3;SPRED2;SMAD2;TYK2;TRAF6
prerank,rRNA binding (GO:0019843),0.22587516616520326,0.5164878760082507,0.9571106094808126,1.0,1.0,6/42,13.56%,MRPL18;ERI1;RRS1;FASTKD5;PPAN;DDX21
prerank,AMP binding (GO:0016208),0.26199657284597083,0.5136506387137928,0.9465648854961832,1.0,1.0,4/11,22.86%,MPPED2;PRKAG1;PYGL;PRKAG3
prerank,phosphate ion binding (GO:0042301),-0.2060134329295085,-0.5089710817049825,0.9877300613496932,1.0,1.0,10/10,79.42%,RPH3A;PDE2A;ADSS1;CHST14;SLC34A2;G6PC1;MTHFD2;RELA;PNP;ADSS2
prerank,antiporter activity (GO:0015297),0.24137449456525234,0.505862538531914,0.9595827900912647,1.0,1.0,3/20,13.09%,SLC35D1;SLC35D2;SLC25A30
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2333621223737795,0.505395878426847,0.9559902200488998,1.0,1.0,2/26,6.42%,B3GNT8;CHSY1
prerank,chemokine receptor binding (GO:0042379),0.22430149356252985,0.49948108757142046,0.9738406658739596,1.0,1.0,2/35,12.82%,CKLF;ITCH
prerank,mechanosensitive ion channel activity (GO:0008381),0.2510753797493276,0.496710785016833,0.9588652482269504,1.0,1.0,3/12,20.21%,PIEZO1;TMEM63A;PIEZO2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.20449124973858446,-0.49643428766399494,0.9821958456973294,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.20449124973858446,-0.49643428766399494,0.9821958456973294,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.22803819697491326,0.4957320727360123,0.9727810650887574,1.0,1.0,7/31,21.55%,AQP1;PKD2;KCNA1;KCNQ4;KCNK5;SLC12A8;KCNC4
prerank,C-C chemokine binding (GO:0019957),0.22927483092918133,0.48896223337410816,0.956687898089172,1.0,1.0,1/22,6.30%,CXCR4
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.2483287111388217,0.4889112631128999,0.9534883720930233,1.0,1.0,1/12,5.78%,FRS2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.25265206201745033,0.4862548988420876,0.9680511182108626,1.0,1.0,10/10,74.75%,ANKRD13D;DNAJB2;DNAJC2;IDE;ANKRD13A;USP15;FAN1;FAAP20;LAPTM5;ANKRD13B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2238241222405556,0.485562842888008,0.9710691823899371,1.0,1.0,5/25,16.03%,SESTD1;ZFYVE1;MAPKAP1;PLEKHA1;DAPP1
prerank,CXCR chemokine receptor binding (GO:0045236),0.24844344529549311,0.484289530475004,0.9647058823529412,1.0,1.0,10/11,58.15%,ITCH;CXCL9;CXCL2;CXCL13;PPBP;PF4;CXCL1;CXCL5;YARS1;CXCL10
prerank,solute:proton symporter activity (GO:0015295),0.23356322110058966,0.47308572460957543,0.9724517906336089,1.0,1.0,5/16,23.19%,SLC39A8;SLC15A4;SLC15A1;SLC17A5;SLC11A2
prerank,peptidase inhibitor activity (GO:0030414),0.21207500498912552,0.47053805354263933,0.9730994152046784,1.0,1.0,9/33,24.03%,CAST;SIMC1;USP14;PROS1;TFPI;RECK;PSMF1;GPC3;ITIH2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.17074684231089116,-0.47029917855576525,1.0,1.0,1.0,13/15,54.46%,SLC4A8;SLC26A2;SLC26A6;CFTR;SLC26A8;SLC4A11;SLC26A4;SLC4A3;SLC26A7;SLC26A3;SLC4A1;SLC26A5;SLC26A1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.21919461075185456,0.4694684785186364,0.9661898569570871,1.0,1.0,1/21,5.78%,FRS2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.19771351989627967,0.46609673333191665,0.9936575052854123,1.0,1.0,4/75,5.88%,PTGR1;RDH11;SORD;RDH12
prerank,kinase inhibitor activity (GO:0019210),0.21490894874996594,0.4651432289556025,0.9785969084423306,1.0,1.0,7/33,20.64%,PARVA;NCK1;CDKN1B;QARS1;SH3BP5;TRIB1;SNCA
prerank,receptor antagonist activity (GO:0048019),0.22148957548354697,0.46103347069652295,0.9735799207397622,1.0,1.0,17/17,77.87%,DKK3;LRPAP1;PXDN;DKK4;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;AGTR2;FST;WFIKKN1;IGSF1;CCL5;ESR2;IL18BP;DKK2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.20538341362768264,0.46017484918154106,0.9891041162227603,1.0,1.0,3/32,9.08%,FTO;KDM2B;HSPBAP1
prerank,cAMP response element binding (GO:0035497),0.23979146596259987,0.45957995777907923,0.9765990639625585,1.0,1.0,4/10,24.20%,CREB5;CREB3L2;ATF7;ATF2
prerank,carbohydrate kinase activity (GO:0019200),-0.1822347771500314,-0.4513195078569955,0.9938080495356038,1.0,1.0,11/11,81.80%,HK1;NAGK;POMK;XYLB;KHK;HK3;GALK1;HK2;GNE;FGGY;GALK2
prerank,CCR chemokine receptor binding (GO:0048020),-0.1339156664362471,-0.44509270344308466,1.0,0.9971467516049523,1.0,28/28,86.64%,CX3CL1;NARS1;CCL13;CCL19;CCL15;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL22;CCL17;CCL24;CCL26;CCL25;CCL14;CNIH4;NES
prerank,solute:anion antiporter activity (GO:0140323),0.225296010180361,0.4426086250950668,0.9861495844875346,1.0,1.0,1/14,8.19%,SLC4A2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.21674446935341382,0.4346300338369759,0.9821182943603851,1.0,1.0,4/14,22.59%,CIAO3;ACO1;ISCA2;SDHB
prerank,chemokine receptor activity (GO:0004950),0.20449723637482137,0.43098038549761286,0.9834815756035579,1.0,1.0,1/24,6.30%,CXCR4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.18395146739476337,0.43077492007110657,0.9958071278825996,1.0,1.0,6/73,12.20%,GALR1;BDKRB2;NPR3;S1PR2;NLRP6;GLP2R
prerank,retinoid X receptor binding (GO:0046965),0.21913596272287691,0.43028137605545075,0.9762611275964391,0.9998767276446874,1.0,3/11,20.21%,NR4A2;ARID5A;MED25
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.22143093578157302,0.4184682133600823,0.9840255591054313,1.0,1.0,4/10,23.28%,DSE;GLCE;DSEL;GNE
prerank,telomerase RNA binding (GO:0070034),0.19454763814768103,0.4178591858814675,0.9849624060150376,0.9980353385847337,1.0,6/22,19.76%,HNRNPU;SMG6;TEP1;EXOSC10;TERT;SNRPB
prerank,cytokine receptor activity (GO:0004896),0.17005024279887046,0.40168389700036916,0.997920997920998,0.9982792892585719,1.0,2/83,5.84%,IL1RL1;LEPR
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.20545701662218918,0.40138895043851414,0.9896142433234422,0.996213071318621,1.0,4/11,23.29%,NAA20;NAA60;NAA40;NAA50
prerank,gated channel activity (GO:0022836),0.17354520988234007,0.35275648904843526,0.9972337482710927,0.9984383162209437,1.0,3/14,20.21%,PIEZO1;TMEM63A;PIEZO2
